<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430804</article-id><article-id pub-id-type="pmcid-ver">PMC12430804.1</article-id><article-id pub-id-type="pmcaid">12430804</article-id><article-id pub-id-type="pmcaiid">12430804</article-id><article-id pub-id-type="pmid">40540534</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002647</article-id><article-id pub-id-type="publisher-id">IJS-D-25-00567</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Cross-Sectional Study</subject></subj-group></article-categories><title-group><article-title>Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="S">Shuangfei</given-names></name><degrees>MSc</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="FT0001" ref-type="fn">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yi</given-names></name><degrees>MD</degrees><email>2574402622@qq.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="FT0001" ref-type="fn">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ye</surname><given-names initials="P">Peng</given-names></name><degrees>PhD</degrees><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="FT0001" ref-type="fn">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="Q">Qin</given-names></name><degrees>PhD</degrees><email>313167836@qq.com</email><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><xref rid="FT0001" ref-type="fn">
<sup>#</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yinan</given-names></name><degrees>MSc</degrees><email>664009703@qq.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yan</given-names></name><degrees>PhD</degrees><email>2574402622@qq.com</email><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="C">Chaogang</given-names></name><degrees>PhD</degrees><email>ycg@whu.edu.cn</email><xref rid="aff5" ref-type="aff">
<sup>e</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ding</surname><given-names initials="J">Jinli</given-names></name><degrees>MD</degrees><email>djl@whu.edu.cn</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Reproductive Medical Center, Renmin Hospital of Wuhan University and Hubei Clinic Research center for Assisted Reproductive Technology and Embryonic Development, Wuhan, China</aff><aff id="aff2"><label>b</label>Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China</aff><aff id="aff3"><label>c</label>Department of Gynecology and obstetrics, Renmin Hospital of Wuhan University, Wuhan, China</aff><aff id="aff4"><label>d</label>Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China</aff><aff id="aff5"><label>e</label>Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University &amp; Hubei Key Laboratory of Tumor Biological Behaviors &amp; Hubei Cancer Clinical Study Center &amp; The Clinical Medical Research Center of Peritoneal Cancer of Wuhan, Wuhan, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding authors. Address: Reproductive Medical Center, Renmin Hospital of Wuhan University and Hubei Clinic Research center for Assisted Reproductive Technology and Embryonic Development, No. 238, Jiefang Road, Wuchang District, Wuhan 430060, China. Tel.: +86 027-88041911.E-mail: <email>djl@whu.edu.cn</email> (J. Ding); Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University &amp; Hubei Key Laboratory of Tumor Biological Behaviors &amp; Hubei Cancer Clinical Study Center &amp; The Clinical Medical Research Center of Peritoneal Cancer of Wuhan, No. 169, Donghu Road, Wuchang District, Wuhan, 430071, China. Tel.: +86 027-67812888.E-mail: <email>ycg@whu.edu.cn</email> (C. Yang) and Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, Wuchang District, Wuhan, 430060, China. Tel.: +86 027-88041911. E-mail: <email>peneyyan@mail.ustc.edu.cn</email> (Y. Zhang).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>5927</fpage><lpage>5940</lpage><history><date date-type="received"><day>27</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbysalicense">https://creativecommons.org/licenses/by-sa/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</ext-link>, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-5927.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-5927.pdf"/><abstract><sec><title>Background:</title><p>Endometriosis is a major contributor to infertility and pelvic pain, which brings a significant burden on family and society. Although the data of endometriosis in Global Burden of Disease (GBD) 2019 was reviewed, no updated analysis has been conducted using GBD 2021, and the disease burden across different age groups has not been analyzed. The aim of this cross-sectional analysis was to provide an up-to-date assessment of the prevalence, incidence, and disability-adjusted life-years (DALYs) of endometriosis from 1990 to 2021 at the global, national, and regional levels.</p></sec><sec><title>Material and methods:</title><p>We obtained data on the prevalence, incidence, and DALYs of endometriosis from GBD 2021. These data were analyzed to provide an overview of the epidemiological trends and disease burden of endometriosis in 204 countries and regions worldwide from 1990 to 2021, and we projected trends through 2040. Health inequality analysis, joinpoint regression analysis, and decomposition analysis were applied to data assessment.</p></sec><sec><title>Results:</title><p>In 2021, the global burden of endometriosis remained substantial, with a total of 22.28 million cases (95% UI: 13.67, 33.69), corresponding to an age-standardized prevalence rate (ASPR) of 1023.8 per 100&#160;000 (95% UI: 627.36, 1549.77). The age-standardized incidence rates (ASIR) was 162.71 (95% UI: 85.21, 265.35) per 100&#160;000, while the age-standardized DALY rate (ASDR) was 94.25 (95% UI: 50.82, 157.73) per 100&#160;000. Regionally, areas with low sociodemographic index (SDI) experienced the highest ASPR, ASIR, and ASDR, while high SDI regions exhibited the lowest rates. Geospatially, Oceania and Eastern Europe displayed the highest ASPR, ASIR, and ASDR. Among countries, Niger had both the highest ASPR and ASDR, and Solomon Islands had the highest ASIR. Women aged 25&#8211;29&#160;years emerged as the most affected group, suggesting that this cohort should be a key focus for interventions. By 2040, the global ASPR of endometriosis is projected decline to 887.89 per 100&#160;000 (95% CI: 530.79, 1245), representing a decrease of 13.28% from 2021. Decomposition analysis showed population growth was the major contributing factor, followed by epidemiologic change.</p></sec><sec><title>Conclusion:</title><p>While the burden of endometriosis has decreased globally from 1990 to 2021, significant disparities remain, especially in low SDI regions. It is necessary to develop better policies and preventive measures to effectively address the range of problems associated with endometriosis.</p></sec></abstract><kwd-group><kwd>crosssectional study</kwd><kwd>disability-adjusted life years</kwd><kwd>endometriosis</kwd><kwd>global burden of disease study 2021</kwd><kwd>incidence</kwd><kwd>prevalence</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Endometriosis is an estrogen dependent chronic disease, characterized by the presence of endometrial-like tissues outside the uterus. The insidious onset, inadequate disease detection, and lack of noninvasive diagnostic methods lead to delayed diagnosis or even misdiagnosis[<xref rid="R1" ref-type="bibr">1</xref>]. The Global Women&#8217;s Health Study (GSWH) reported an average diagnostic delay of endometriosis of 3&#8211;10&#160;years[<xref rid="R2" ref-type="bibr">2</xref>]. The incidence rate of endometriosis has been reported to be increasing in recent years. Data from 2018 indicate that endometriosis affected about 190 million women worldwide, roughly 10 to 15% of women at reproductive age[<xref rid="R3" ref-type="bibr">3</xref>]. Notably, since the gold standard for diagnosing of endometriosis is laparoscopic surgery, its true prevalence is unknown[<xref rid="R4" ref-type="bibr">4</xref>]. Endometriosis has numerous harmful effects on women. Notably, infertility is a major consequence &#8211; approximately 50% of infertile women have endometriosis[<xref rid="R5" ref-type="bibr">5</xref>]. In addition, women with endometriosis commonly experience dyspareunia[<xref rid="R6" ref-type="bibr">6</xref>], pelvic pain and dysmenorrhea, pregnancy loss, gestational diabetes mellitus and hypertensive disorders of pregnancy[<xref rid="R7" ref-type="bibr">7</xref>]. Patients with endometriosis also have a significantly increased risk of depression and anxiety[<xref rid="R8" ref-type="bibr">8</xref>], autoimmune diseases[<xref rid="R9" ref-type="bibr">9</xref>], migraines[<xref rid="R10" ref-type="bibr">10</xref>], breast, or ovarian cancer<sup>[<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>]</sup>. These comorbid conditions can greatly affect personal relationships, educational and employment opportunities, and overall quality of life<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup>. Although endometriosis is a benign disease, its malignant-like behavior &#8211; such as invasion, implantation, and recurrence[<xref rid="R15" ref-type="bibr">15</xref>] &#8211; indicate that prevention of this disease is far more important than treatment.</p><p>Endometriosis remains a challenging condition that significantly affects patients&#8217; quality of life and contributes to a substantial long-standing medical burden. The direct medical costs of treating endometriosis, as well as the indirect costs (lost work and productivity), are very high. In fact, the medical costs of endometriosis have been estimated to be similar to those of other chronic conditions such as diabetes and heart disease[<xref rid="R16" ref-type="bibr">16</xref>], which ere major threats to the economy and society. The GSWH estimated the average annual cost of endometriosis at $9579, whereas a study from Australian found that the average annual cost of $20&#160;898, with the largest proportion of this cost attributable to lost productivity[<xref rid="R2" ref-type="bibr">2</xref>]. Soliman et al. conducted a systematic literature review (2000&#8211;2013) of endometriosis costs. They found that the annual direct cost per patient ranged from $1109 (Canada) to $12&#160;118 (USA), and the annual indirect cost ranged from $3314 (Austria) to $15&#160;737 (USA)[<xref rid="R17" ref-type="bibr">17</xref>]. These data indicate that the economic burden of endometriosis varies greatly by country but is substantial everywhere. Therefore, comprehensive and up-to-date epidemiological data are indispensable for policymakers and researchers in developing effective response strategies.</p><p>Prior to our work, three studies have analyzed the burden of endometriosis. One study focused on the incidence and prevalence rates based on Global Burden of Disease Study (GBD) 2017[<xref rid="R18" ref-type="bibr">18</xref>]. Another examined the burden in China and looked only mortality and disability-adjusted life-years (DALYs) rates[<xref rid="R19" ref-type="bibr">19</xref>]. The third was a brief global assessment using GBD 2019, reporting on incidence and DALYs[<xref rid="R20" ref-type="bibr">20</xref>]. GBD 2021 is a comprehensive global dataset of disease and related injuries[<xref rid="R21" ref-type="bibr">21</xref>]. To inform policy with the latest data on endometriosis trends from 1990 to 2021, the present study utilizes the most up-to-date GBD 2021 estimates. This study represents the first comprehensive investigation to utilize decomposition analysis and cross-country inequality assessment in evaluating global trends and disparities in endometriosis burden. Furthermore, we have conducted a pioneering age-stratified analysis of endometriosis burden, offering unprecedented insights into age-specific disease patterns and enabling evidence-based policy formulation for targeted age-group interventions. By utilizing the latest comprehensive data from GBD 2021, the research clarifies the impacts of demographic, age-related, and epidemiological factors on disease burden and provides the first projections of future trends in endometriosis burden.<boxed-text id="UBT0001" position="float" orientation="portrait"><sec><title>HIGHLIGHTS</title><p>
<list list-type="bullet"><list-item><p>The aim of this study was to provide an up-to-date assessment of the prevalence, incidence, and disability-adjusted life years of endometriosis from 1990 to 2021 at the global, national, and regional levels.</p></list-item><list-item><p>The burden of endometriosis has decreased globally from 1990 to 2021, mainly due to population growth and epidemiologic change.</p></list-item><list-item><p>The prevalence rate of endometriosis is projected to decrease by 2040.</p></list-item><list-item><p>The burden associated with endometriosis primarily affected women aged 25&#8211;29&#160;years.</p></list-item></list></p></sec></boxed-text></p><p>The work has been reported in line with the Strengthening The Reporting Of Cohort Studies in Surgery (STROCSS) criteria[<xref rid="R22" ref-type="bibr">22</xref>].</p></sec><sec sec-type="methods"><title>Materials and methods</title><sec><title>Data sources</title><p>All data in this cross-sectional analysis were retrieved from the GBD 2021 using the GBD results tool on the Institute for Health Metrics and Evaluation website. GBD 2021 provides estimates for 371 diseases and injuries across 204 countries and territories, 21 countries with subnational locations, for 25 age groups, over the years 1990&#8211;2021[<xref rid="R23" ref-type="bibr">23</xref>]. In GBD 2021, endometriosis case definitions were based on ICD-10 codes N80.0-N80.9 and corresponding ICD-9 codes 617-617.9. These codes comprehensively encompass uterine, ovarian, tubal, pelvic peritoneal, rectovaginal septum and vaginal, intestinal, cutaneous, as well as other specified or unspecified forms of endometriosis. We obtained incident cases, prevalent cases, and DALYS data for endometriosis from GBD 2021 databases. DALYs refers to the summation of years of life lost (YLLs) and years lived with disability (YLDs). YLLs are calculated as the estimated number of deaths and the product of the standardized life expectancy based on the age at death. YLDs are calculated by the prevalence of an individual consequence of a disease multiplied by its corresponding disability weight[<xref rid="R24" ref-type="bibr">24</xref>]. In addition, we also used sociodemographic index (SDI) to gauge social development in various countries and regions. The SDI is a composite index, defined as the geometric mean of three standardized indicators: the total fertility rate for women under age 25, mean years of schooling for those aged 15 years and older, and lag-distributed income per capita. This index reflects the level of social development at the national level across different countries and territories[<xref rid="R25" ref-type="bibr">25</xref>].</p></sec><sec><title>Statistical analysis</title><p>We assessed the trends by age group using GBD 2021 age strata: 15&#8211;19, 20&#8211;24, 25&#8211;29, 30&#8211;34, 35&#8211;39, 40&#8211;44, 45&#8211;49, and 50&#8211;54&#160;years. All rates were age-standardized using the direct standardization method by calling the age-adjust direct function from the epitools package. The standard population used for the standardization was the 2021 global standard population estimated by GBD<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R26" ref-type="bibr">26</xref>]</sup>.</p></sec><sec><title>Temporal trends</title><p>The joinpoint regression model identifies trends and key turning points in disease burden by calculating the sum of squared residuals between estimated and observed values. Compared to traditional linear trend analysis, joinpoint regression accurately captures dynamic changes in disease burden across different time periods[<xref rid="R27" ref-type="bibr">27</xref>]. We used joinpoint regression analysis to segment long-term trends into meaningful intervals, estimating the annual percentage change (APC), average annual percentage change (AAPC), and their 95% confidence intervals (CI). For ASIR, ASPR, and ASDR of endometriosis, an APC or AAPC &gt; 0 with <italic toggle="yes">P</italic> &lt; 0.05 indicated a significantly increasing trend, APC or AAPC &lt; 0 with <italic toggle="yes">P</italic> &lt; 0.05 indicated a decreasing trend, and a 95% CI including 0 with <italic toggle="yes">P</italic> &#8805; 0.05 indicated a stable trend<sup>[<xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref>]</sup>. To comprehensively assess the long-term trends in endometriosis burden, we calculated the estimated annual percentage change (EAPC) as a key metric for evaluating temporal patterns. This approach was systematically applied to quantify trends in prevalence, incidence, and DALYs associated with endometriosis[<xref rid="R30" ref-type="bibr">30</xref>].</p></sec><sec><title>Decomposition analysis</title><p>Decomposition analysis is a statistical methodology designed to quantify the relative contributions of diverse driving factors to temporal or spatial variations in endometriosis-related disease burden metrics, including incidence, prevalence and DALYs. Using the Das Gupta method, we decomposed changes in endometriosis burden from 1990 to 2021 into contributions from aging, population growth, and epidemiological changes. This approach provides a clearer understanding of how each factor has shaped the trends. Unlike traditional methods like linear regression, decomposition analysis isolates the independent effect of each factor on the overall burden change, helping identify key drivers of global trends<sup>[<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>]</sup>.</p></sec><sec><title>Cross-country inequality analysis</title><p>Health inequality monitoring provides a foundation for evidence-based health planning and can inform policies, programs, and practices to reduce disparities in health distribution[<xref rid="R33" ref-type="bibr">33</xref>].The Slope Index of Inequality (SII) and the Concentration Index were used to quantify the burden inequality of endometriosis globally and across 21 GBD regions. The SII was calculated by regressing the age-standardized endometriosis rate on the SDI, using the midpoint of the cumulative population distribution ranked by SDI. To evaluate changes in health inequality, we analyzed data from 204 countries and territories between 1990 and 2021. A robust regression model (RLM), instead of an ordinary linear regression model, was applied to better manage bias and heterogeneity. This approach reduces sensitivity to outliers, minimizing bias from data variability or extreme values for a more accurate representation of health inequalities. Additionally, the concentration index was calculated by plotting the cumulative proportion of age-standard rate with the cumulative population distribution ranked by SDI and measuring the area under the Lorenz curve<sup>[<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>]</sup>.</p></sec><sec><title>Bayesian Age-Period-Cohort model projection</title><p>Because the BAPC model can handle the complex, high-dimensional, and sparse data typical of large-scale epidemiological studies like GBD 2021, this approach was used to forecast the global burden of endometriosis from 2022 to 2040. The Integrated Nested Laplace Approximations (INLA) framework and the BAPC model were employed to predict future trends. The INLA framework was utilized alongside the BAPC model to approximate the marginal posterior distributions, effectively avoiding the mixing and convergence issues associated with conventional Bayesian methods that rely on Markov chain Monte Carlo sampling techniques<sup>[<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>]</sup>. These models assume the logit risk of incidence, prevalence and DALYS for a given age group and period can be modeled as a linear function of age, period, and cohort effects, thereby enabling an in-depth analysis of temporal changes in mortality. Furthermore, they allow for various combinations of age, period, and cohort influences, including constant or linear trends modeled as first- or second-order random walks, to capture diverse temporal dynamics<sup>[<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R39" ref-type="bibr">39</xref>]</sup>.The analyses is conducted using the default parameters in the BAPC package. The specific parameter information can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://rdrr.io/rforge/BAPC/man/BAPC.html" ext-link-type="uri">https://rdrr.io/rforge/BAPC/man/BAPC.html</ext-link>.</p><p>Perform Joinpoint regression by invoking the Joinpoint command-line version via function calls. The SII and Concentration Index were calculated through Stata 16.0. The preceding BAPC analysis is based on the R package &#8220;BAPC&#8221; (Version 0.0.36) and &#8220;INLA&#8221; (Version 23.09.09). Stata 16 and R software (Version 4.3.3) were used for data analysis and visualization and two-sided <italic toggle="yes">P</italic> &lt; 0.05 was considered statistically significant.</p><p>The data analysis of this study was conducted from 1 November 2024 to 15 November 2024. AI was not used in the design, conduct, data analysis, or manuscript preparation of this study.</p></sec></sec><sec sec-type="results"><title>Result</title><sec><title>Global level</title><p>In 2021, the global burden of endometriosis was substantial, with an estimated 22.28 million cases (95% UI: 13.67, 33.69), representing a 12.11% increase from 1990. Despite the rise in the absolute number, there was a slight decrease for the ASPR, from 1391.65 per 100&#160;000 (95% UI: 842.39, 2129.67) in 1990 to 1023.8 per 100&#160;000 (95% UI: 627.36, 1549.77) in 2021 (Table <xref rid="T1" ref-type="table">1</xref>, Figure <xref rid="F1" ref-type="fig">1</xref>A). The global incidence in 2021 was 3.45 million cases (95% UI: 1.80, 5.64), marking a 3.51% increase from 1990. Correspondingly, the ASIR displayed a decline from 219.92 per 100&#160;000 (95% UI: 113.45, 361.04) in 1990 to 162.71 per 100,000 (95% UI: 85.21, 265.35) in 2021. This downward trend in incidence is reflected by an EAPC for ASIR of &#8722;1 (95% CI:&#160;&#8722;1.05,&#160;&#8722;0.96) (Table <xref rid="T2" ref-type="table">2</xref>, Figure <xref rid="F1" ref-type="fig">1</xref>B). The global DALYs due to endometriosis in 2021 totaled 2.05 million (95% UI: 1.11, 3.43), with an ASDR of 94.25 per 100&#160;000 (95% UI: 50.82, 157.73) and an EAPC of &#8722;1.01 (95% CI:&#160;&#8722;1.06,&#160;&#8722;0.96) (Table S1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure <xref rid="F1" ref-type="fig">1</xref>C).<fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Temporal trend changes in ASPR (A), ASIR (B), and ASDR (C) for endometriosis globally and in various SDI regions from 1990 to 2021 based on the Joinpoint regression model.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-5927-g001.jpg"/></fig>
<table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p>The prevalence of endometriosis in 1990 and 2021, and changes from 1990 to 2021 at the global level and different regions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">location</th><th align="center" rowspan="1" colspan="1">No. (95% UI) 1990</th><th align="center" rowspan="1" colspan="1">No. (95% UI) 2021</th><th align="center" rowspan="1" colspan="1">ASPR No.&#160;&#215;&#160;10<sup>&#8722;5</sup> (95% UI)</th><th align="center" rowspan="1" colspan="1">ASPR No.&#160;&#215;&#160;10<sup>&#8722;5</sup> (95% UI)</th><th align="center" rowspan="1" colspan="1">EAPC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Global</td><td align="center" rowspan="1" colspan="1">19&#160;869&#160;195.64 (11&#160;990&#160;157.75, 30&#160;495&#160;669.26)</td><td align="center" rowspan="1" colspan="1">22&#160;275&#160;015.21 (13&#160;665&#160;028.93, 33&#160;685&#160;040.5)</td><td align="center" rowspan="1" colspan="1">1391.65 (842.39, 2129.67)</td><td align="center" rowspan="1" colspan="1">1023.8 (627.36, 1549.77)</td><td align="center" rowspan="1" colspan="1">&#8722;1.02 (&#8722;1.07, &#8722;0.97)</td></tr><tr><td align="left" rowspan="1" colspan="1">High SDI</td><td align="center" rowspan="1" colspan="1">2&#160;784&#160;337.01 (1&#160;678&#160;168, 4&#160;323&#160;027.51)</td><td align="center" rowspan="1" colspan="1">2&#160;495&#160;271.47 (1&#160;567&#160;680.71, 3&#160;697&#160;457.56)</td><td align="center" rowspan="1" colspan="1">1087.6 (655.11, 1691.54)</td><td align="center" rowspan="1" colspan="1">874.89 (545.91, 1307.15)</td><td align="center" rowspan="1" colspan="1">&#8722;0.85 (&#8722;0.94, &#8722;0.76)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-middle SDI</td><td align="center" rowspan="1" colspan="1">3&#160;627&#160;103.19 (2&#160;172&#160;525.53, 5&#160;608&#160;611.72)</td><td align="center" rowspan="1" colspan="1">3&#160;410&#160;962.02 (2&#160;128&#160;858.19, 5&#160;094&#160;600.79)</td><td align="center" rowspan="1" colspan="1">1190.63 (714.74, 1837.97)</td><td align="center" rowspan="1" colspan="1">944.37 (587.54, 1415.42)</td><td align="center" rowspan="1" colspan="1">&#8722;0.71 (&#8722;0.81, &#8722;0.62)</td></tr><tr><td align="left" rowspan="1" colspan="1">Middle SDI</td><td align="center" rowspan="1" colspan="1">5&#160;892&#160;115.28 (3&#160;517&#160;686.06, 9&#160;102&#160;898.61)</td><td align="center" rowspan="1" colspan="1">6&#160;549&#160;196.08 (4&#160;002&#160;699.48, 9&#160;953&#160;701.91)</td><td align="center" rowspan="1" colspan="1">1268.23 (760.61, 1951.64)</td><td align="center" rowspan="1" colspan="1">930.51 (567.48, 1416.85)</td><td align="center" rowspan="1" colspan="1">&#8722;1.04 (&#8722;1.12, &#8722;0.96)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low-middle SDI</td><td align="center" rowspan="1" colspan="1">5&#160;225&#160;146.81 (3&#160;156&#160;078.22, 7&#160;996&#160;121.85)</td><td align="center" rowspan="1" colspan="1">6&#160;091&#160;634.17 (3&#160;706&#160;965.06, 9&#160;312&#160;503.86)</td><td align="center" rowspan="1" colspan="1">1845.32 (1118.04, 2808.57)</td><td align="center" rowspan="1" colspan="1">1109.54 (676.14, 1693.46)</td><td align="center" rowspan="1" colspan="1">&#8722;1.67 (&#8722;1.7, &#8722;1.64)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low SDI</td><td align="center" rowspan="1" colspan="1">2&#160;324&#160;260.43 (1&#160;403&#160;825.98, 3&#160;553&#160;918.19)</td><td align="center" rowspan="1" colspan="1">3&#160;710&#160;059.28 (2&#160;210&#160;282.35, 5&#160;680&#160;442.28)</td><td align="center" rowspan="1" colspan="1">2022.88 (1224.21, 3077.64)</td><td align="center" rowspan="1" colspan="1">1314 (786.61, 2002.31)</td><td align="center" rowspan="1" colspan="1">&#8722;1.4 (&#8722;1.47, &#8722;1.32)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-income Asia Pacific</td><td align="center" rowspan="1" colspan="1">699&#160;270.28 (412&#160;162.58, 1&#160;078&#160;919.64)</td><td align="center" rowspan="1" colspan="1">545&#160;354.82 (340&#160;224.94, 804&#160;799.06)</td><td align="center" rowspan="1" colspan="1">1370.19 (805.94, 2120.76)</td><td align="center" rowspan="1" colspan="1">1174.55 (726.31, 1761.71)</td><td align="center" rowspan="1" colspan="1">&#8722;0.62 (&#8722;0.73, &#8722;0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-income North America</td><td align="center" rowspan="1" colspan="1">797&#160;899.34 (449&#160;704.4, 1&#160;279&#160;317.74)</td><td align="center" rowspan="1" colspan="1">594&#160;499.2 (374&#160;298.27, 874&#160;670.98)</td><td align="center" rowspan="1" colspan="1">934.28 (525.39, 1502.48)</td><td align="center" rowspan="1" colspan="1">609.96 (381.66, 902.65)</td><td align="center" rowspan="1" colspan="1">&#8722;1.91 (&#8722;2.08, &#8722;1.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">Western Europe</td><td align="center" rowspan="1" colspan="1">961&#160;930.5 (574&#160;435.53, 1&#160;504&#160;198.02)</td><td align="center" rowspan="1" colspan="1">900&#160;964.47 (561&#160;312.07, 1&#160;371&#160;058.82)</td><td align="center" rowspan="1" colspan="1">893.54 (531.89, 1403.72)</td><td align="center" rowspan="1" colspan="1">851.32 (526.04, 1310.62)</td><td align="center" rowspan="1" colspan="1">&#8722;0.08 (&#8722;0.1, &#8722;0.05)</td></tr><tr><td align="left" rowspan="1" colspan="1">Australasia</td><td align="center" rowspan="1" colspan="1">67&#160;389.7 (40&#160;323.84, 106&#160;196.72)</td><td align="center" rowspan="1" colspan="1">80&#160;842.14 (49&#160;536.93, 124&#160;254.89)</td><td align="center" rowspan="1" colspan="1">1138.39 (681.06, 1796.84)</td><td align="center" rowspan="1" colspan="1">991.62 (603.13, 1535.33)</td><td align="center" rowspan="1" colspan="1">&#8722;0.28 (&#8722;0.36, &#8722;0.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Andean Latin America</td><td align="center" rowspan="1" colspan="1">115&#160;457.46 (69&#160;203.37, 178&#160;292.34)</td><td align="center" rowspan="1" colspan="1">155&#160;218.84 (92&#160;448.91, 242&#160;314.08)</td><td align="center" rowspan="1" colspan="1">1172.61 (707.03, 1798.98)</td><td align="center" rowspan="1" colspan="1">801.11 (477.49, 1249.9)</td><td align="center" rowspan="1" colspan="1">&#8722;1.15 (&#8722;1.22, &#8722;1.07)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tropical Latin America</td><td align="center" rowspan="1" colspan="1">472&#160;933.7 (270&#160;237.82, 760&#160;208.8)</td><td align="center" rowspan="1" colspan="1">623&#160;743.9 (383&#160;238.37, 954&#160;264.75)</td><td align="center" rowspan="1" colspan="1">1118.81 (642.14, 1791.11)</td><td align="center" rowspan="1" colspan="1">911.41 (559.57, 1396.39)</td><td align="center" rowspan="1" colspan="1">&#8722;1.06 (&#8722;1.29, &#8722;0.83)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Latin America</td><td align="center" rowspan="1" colspan="1">498&#160;631.88 (300&#160;192.12, 768&#160;646.99)</td><td align="center" rowspan="1" colspan="1">575&#160;740.85 (346&#160;604.34, 888&#160;888.32)</td><td align="center" rowspan="1" colspan="1">1146.12 (693.17, 1756.83)</td><td align="center" rowspan="1" colspan="1">760.38 (457.6, 1174.84)</td><td align="center" rowspan="1" colspan="1">&#8722;1.27 (&#8722;1.37, &#8722;1.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southern Latin America</td><td align="center" rowspan="1" colspan="1">127&#160;546.6 (74&#160;874.98, 199&#160;073.84)</td><td align="center" rowspan="1" colspan="1">159&#160;083.96 (99&#160;568.36, 233&#160;997.67)</td><td align="center" rowspan="1" colspan="1">952.15 (559.97, 1482.56)</td><td align="center" rowspan="1" colspan="1">800.43 (499.17, 1181.74)</td><td align="center" rowspan="1" colspan="1">&#8722;0.41 (&#8722;0.53, &#8722;0.29)</td></tr><tr><td align="left" rowspan="1" colspan="1">Caribbean</td><td align="center" rowspan="1" colspan="1">110&#160;052.33 (65&#160;334.33, 171&#160;653.91)</td><td align="center" rowspan="1" colspan="1">112&#160;185.19 (66&#160;316.06,176&#160;035.4)</td><td align="center" rowspan="1" colspan="1">1109.12 (661.19, 1720.47)</td><td align="center" rowspan="1" colspan="1">832.44 (491.46, 1308.1)</td><td align="center" rowspan="1" colspan="1">&#8722;0.86 (&#8722;0.9, &#8722;0.83)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Europe</td><td align="center" rowspan="1" colspan="1">329&#160;932.64 (204&#160;292.97, 505&#160;114.74)</td><td align="center" rowspan="1" colspan="1">260&#160;161.75 (160&#160;645, 397&#160;475.63)</td><td align="center" rowspan="1" colspan="1">969.3 (600.28, 1484.2)</td><td align="center" rowspan="1" colspan="1">885.75 (546.61, 1358.24)</td><td align="center" rowspan="1" colspan="1">&#8722;0.22 (&#8722;0.36, &#8722;0.07)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eastern Europe</td><td align="center" rowspan="1" colspan="1">1&#160;038&#160;437.89 (640&#160;566.25, 1&#160;577&#160;704.6)</td><td align="center" rowspan="1" colspan="1">882&#160;964.32 (544&#160;948.56, 1&#160;342&#160;805.72)</td><td align="center" rowspan="1" colspan="1">1618.68 (997.4, 2460.79)</td><td align="center" rowspan="1" colspan="1">1585.38 (977.34, 2415.93)</td><td align="center" rowspan="1" colspan="1">0.32 (0.15, 0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Asia</td><td align="center" rowspan="1" colspan="1">238&#160;771.42 (146&#160;243.83, 367&#160;485.14)</td><td align="center" rowspan="1" colspan="1">278&#160;735.7 (172&#160;217.95, 424&#160;801.53)</td><td align="center" rowspan="1" colspan="1">1285.56 (787.62, 1973.81)</td><td align="center" rowspan="1" colspan="1">1017.38 (627.87, 1550.01)</td><td align="center" rowspan="1" colspan="1">&#8722;0.43 (&#8722;0.62, &#8722;0.25)</td></tr><tr><td align="left" rowspan="1" colspan="1">North Africa and Middle East</td><td align="center" rowspan="1" colspan="1">1&#160;504&#160;316.73 (899&#160;207.97, 2&#160;308&#160;291.14)</td><td align="center" rowspan="1" colspan="1">2&#160;200&#160;421.08 (1&#160;326&#160;806.04, 3&#160;377&#160;916.73)</td><td align="center" rowspan="1" colspan="1">1847.19 (1112.88, 2815.54)</td><td align="center" rowspan="1" colspan="1">1258.23 (759.35, 1930.54)</td><td align="center" rowspan="1" colspan="1">&#8722;1.3 (&#8722;1.36, &#8722;1.24)</td></tr><tr><td align="left" rowspan="1" colspan="1">South Asia</td><td align="center" rowspan="1" colspan="1">4&#160;929&#160;562.83 (2&#160;990&#160;875.79, 7&#160;490&#160;020.67)</td><td align="center" rowspan="1" colspan="1">5&#160;866&#160;273.34 (3&#160;561&#160;973.73, 8&#160;968&#160;531.5)</td><td align="center" rowspan="1" colspan="1">1849.61 (1124.62, 2796.92)</td><td align="center" rowspan="1" colspan="1">1087.35 (661.04, 1660.22)</td><td align="center" rowspan="1" colspan="1">&#8722;1.77 (&#8722;1.8, &#8722;1.74)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southeast Asia</td><td align="center" rowspan="1" colspan="1">1&#160;932&#160;516.3 (1&#160;192&#160;520.09, 2&#160;939&#160;459.06)</td><td align="center" rowspan="1" colspan="1">2&#160;420&#160;576.08 (1&#160;479&#160;728.44, 3&#160;662&#160;611.18)</td><td align="center" rowspan="1" colspan="1">1533.41 (948.98, 2322.65)</td><td align="center" rowspan="1" colspan="1">1176.58 (718.53, 1782.27)</td><td align="center" rowspan="1" colspan="1">&#8722;0.8 (&#8722;0.83, &#8722;0.77)</td></tr><tr><td align="left" rowspan="1" colspan="1">East Asia</td><td align="center" rowspan="1" colspan="1">4&#160;003&#160;165.85 (2&#160;282&#160;924.05, 6&#160;303&#160;923.54)</td><td align="center" rowspan="1" colspan="1">3&#160;116&#160;327.55 (1&#160;901&#160;911.29, 4&#160;693&#160;324.04)</td><td align="center" rowspan="1" colspan="1">1158.72 (666.05, 1816.93)</td><td align="center" rowspan="1" colspan="1">752.81 (454.4, 1142.13)</td><td align="center" rowspan="1" colspan="1">&#8722;1.53 (&#8722;1.7, &#8722;1.35)</td></tr><tr><td align="left" rowspan="1" colspan="1">Oceania</td><td align="center" rowspan="1" colspan="1">35&#160;141.66 (20&#160;938.1, 54&#160;210.72)</td><td align="center" rowspan="1" colspan="1">67&#160;931.47 (39&#160;387.58, 103&#160;825.07)</td><td align="center" rowspan="1" colspan="1">2209.61 (1325.2, 3381.62)</td><td align="center" rowspan="1" colspan="1">1832.2 (1066.77, 2790.6)</td><td align="center" rowspan="1" colspan="1">&#8722;0.59 (&#8722;0.61, &#8722;0.57)</td></tr><tr><td align="left" rowspan="1" colspan="1">Western Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">828&#160;383.98 (505&#160;017.68, 1&#160;270&#160;317.38)</td><td align="center" rowspan="1" colspan="1">1&#160;620&#160;504.96 (982&#160;404.45, 2&#160;439&#160;381.17)</td><td align="center" rowspan="1" colspan="1">1853.09 (1134.14, 2823.16)</td><td align="center" rowspan="1" colspan="1">1313.22 (798.96, 1969.77)</td><td align="center" rowspan="1" colspan="1">&#8722;1.05 (&#8722;1.11, &#8722;1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eastern Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">738&#160;162.75 (446&#160;995.22, 1&#160;138&#160;694.89)</td><td align="center" rowspan="1" colspan="1">1&#160;148&#160;923.38 (681&#160;259.58, 1&#160;768&#160;902.18)</td><td align="center" rowspan="1" colspan="1">1679.14 (1020.55, 2575.18)</td><td align="center" rowspan="1" colspan="1">1049.89 (626.71, 1606.38)</td><td align="center" rowspan="1" colspan="1">&#8722;1.51 (&#8722;1.56, &#8722;1.45)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">246&#160;937.37 (147&#160;743.33, 381&#160;071.67)</td><td align="center" rowspan="1" colspan="1">405&#160;555.44 (240&#160;277.49, 633&#160;287.46)</td><td align="center" rowspan="1" colspan="1">1932.61 (1158.93, 2961.15)</td><td align="center" rowspan="1" colspan="1">1204.54 (717.92, 1873.09)</td><td align="center" rowspan="1" colspan="1">&#8722;1.44 (&#8722;1.57, &#8722;1.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southern Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">192&#160;754.42 (117&#160;147.03, 295&#160;505.13)</td><td align="center" rowspan="1" colspan="1">259&#160;006.76 (156&#160;887.64, 396&#160;097.81)</td><td align="center" rowspan="1" colspan="1">1390.61 (847.43, 2121.95)</td><td align="center" rowspan="1" colspan="1">1084.29 (656.94, 1656.06)</td><td align="center" rowspan="1" colspan="1">&#8722;0.75 (&#8722;0.79, &#8722;0.72)</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>ASPR, age-standardized prevalence rates; EAPC, estimated annual percentage change; SDI, Socio-demographic Index.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="T2" orientation="landscape"><label>Table 2</label><caption><p>The incidence of endometriosis in 1990 and 2021, and changes from 1990 to 2021 at the global level and different regions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">location</th><th align="center" rowspan="1" colspan="1">No. (95% UI) 1990</th><th align="center" rowspan="1" colspan="1">No. (95% UI) 2021</th><th align="center" rowspan="1" colspan="1">ASR No.&#160;&#215;&#160;10<sup>&#8722;5</sup> (95% UI) 1990</th><th align="center" rowspan="1" colspan="1">ASR No.&#160;&#215;&#160;10<sup>&#8722;5</sup> (95% UI) 2021</th><th align="center" rowspan="1" colspan="1">EAPC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Global</td><td align="center" rowspan="1" colspan="1">3&#160;330&#160;200.05 (1&#160;737&#160;295.21, 5&#160;432&#160;158.31)</td><td align="center" rowspan="1" colspan="1">3&#160;447&#160;125.88 (1&#160;795&#160;822.76, 5&#160;636&#160;732.96)</td><td align="center" rowspan="1" colspan="1">219.92 (113.45, 361.04)</td><td align="center" rowspan="1" colspan="1">162.71 (85.21, 265.35)</td><td align="center" rowspan="1" colspan="1">&#8722;1 (&#8722;1.05, &#8722;0.96)</td></tr><tr><td align="left" rowspan="1" colspan="1">High SDI</td><td align="center" rowspan="1" colspan="1">437&#160;908.4 (216&#160;854.7, 742&#160;189.45)</td><td align="center" rowspan="1" colspan="1">358&#160;019.31 (180&#160;686.32, 605&#160;212.39)</td><td align="center" rowspan="1" colspan="1">176.99 (88.08,299.58)</td><td align="center" rowspan="1" colspan="1">138.51 (70.91, 233.6)</td><td align="center" rowspan="1" colspan="1">&#8722;0.92 (&#8722;0.99, &#8722;0.85)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-middle SDI</td><td align="center" rowspan="1" colspan="1">593&#160;606.46 (302&#160;244.77, 979&#160;980.51)</td><td align="center" rowspan="1" colspan="1">488&#160;882.81 (248&#160;635.12, 806&#160;322.97)</td><td align="center" rowspan="1" colspan="1">191 (96.75, 316.37)</td><td align="center" rowspan="1" colspan="1">152.69 (79.85, 248.32)</td><td align="center" rowspan="1" colspan="1">&#8722;0.72 (&#8722;0.82,-0.62)</td></tr><tr><td align="left" rowspan="1" colspan="1">Middle SDI</td><td align="center" rowspan="1" colspan="1">1&#160;049&#160;820.76 (542&#160;005.09, 1&#160;713&#160;276.38)</td><td align="center" rowspan="1" colspan="1">1&#160;008&#160;051.89 (516&#160;152.71, 1&#160;657&#160;623.21)</td><td align="center" rowspan="1" colspan="1">206.38 (104.83, 339.96)</td><td align="center" rowspan="1" colspan="1">151.46 (78.47, 247.69)</td><td align="center" rowspan="1" colspan="1">&#8722;1.04 (&#8722;1.12, &#8722;0.97)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low-middle SDI</td><td align="center" rowspan="1" colspan="1">863&#160;042.96 (458&#160;621.65, 1&#160;396&#160;094.88)</td><td align="center" rowspan="1" colspan="1">981&#160;567.48 (512&#160;392.16, 1&#160;598&#160;015.85)</td><td align="center" rowspan="1" colspan="1">274.73 (143.12, 449.11)</td><td align="center" rowspan="1" colspan="1">173.02 (89.73, 282.72)</td><td align="center" rowspan="1" colspan="1">&#8722;1.5 (&#8722;1.52, &#8722;1.47)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low SDI</td><td align="center" rowspan="1" colspan="1">383&#160;153.46 (204&#160;645.54, 618&#160;792.09)</td><td align="center" rowspan="1" colspan="1">607&#160;883.49 (321&#160;234.42, 993&#160;013.98)</td><td align="center" rowspan="1" colspan="1">294.71 (153.79, 482.12)</td><td align="center" rowspan="1" colspan="1">190.36 (98.35, 314.8)</td><td align="center" rowspan="1" colspan="1">&#8722;1.41 (&#8722;1.46, &#8722;1.36)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-income Asia Pacific</td><td align="center" rowspan="1" colspan="1">110&#160;470.72 (53&#160;649.76, 185&#160;277.98)</td><td align="center" rowspan="1" colspan="1">77&#160;235.23 (37&#160;586.51, 131&#160;144.43)</td><td align="center" rowspan="1" colspan="1">221.02 (107.33, 370.06)</td><td align="center" rowspan="1" colspan="1">191.9 (94.86, 325.39)</td><td align="center" rowspan="1" colspan="1">&#8722;0.53 (&#8722;0.63, &#8722;0.42)</td></tr><tr><td align="left" rowspan="1" colspan="1">High-income North America</td><td align="center" rowspan="1" colspan="1">133&#160;506.05 (64&#160;090.74, 232&#160;842.97)</td><td align="center" rowspan="1" colspan="1">91&#160;185.88 (45&#160;320.03, 153&#160;289.74)</td><td align="center" rowspan="1" colspan="1">159.6 (76.58, 279.24)</td><td align="center" rowspan="1" colspan="1">99.5 (49.71,167.14)</td><td align="center" rowspan="1" colspan="1">&#8722;2.07 (&#8722;2.24, &#8722;1.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Western Europe</td><td align="center" rowspan="1" colspan="1">140&#160;947.05 (66&#160;717.49, 251&#160;893.26)</td><td align="center" rowspan="1" colspan="1">126&#160;349.52 (60&#160;855.51, 223&#160;814.55)</td><td align="center" rowspan="1" colspan="1">137.35 (65.52, 245.78)</td><td align="center" rowspan="1" colspan="1">133.17 (65.18, 235.44)</td><td align="center" rowspan="1" colspan="1">0.02 (&#8722;0.02, 0.07)</td></tr><tr><td align="left" rowspan="1" colspan="1">Australasia</td><td align="center" rowspan="1" colspan="1">10&#160;749.31 (5188.26, 18&#160;598.09)</td><td align="center" rowspan="1" colspan="1">12&#160;016.69 (5663.16,21&#160;195.61)</td><td align="center" rowspan="1" colspan="1">185.13 (89.59, 320.48)</td><td align="center" rowspan="1" colspan="1">162.48 (77.59, 286.43)</td><td align="center" rowspan="1" colspan="1">&#8722;0.25 (&#8722;0.33, &#8722;0.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">Andean Latin America</td><td align="center" rowspan="1" colspan="1">20&#160;893.91 (10&#160;723.34, 34&#160;288.3)</td><td align="center" rowspan="1" colspan="1">25&#160;037.61 (12&#160;522.52, 41&#160;937.44)</td><td align="center" rowspan="1" colspan="1">191.73 (96.94, 317.28)</td><td align="center" rowspan="1" colspan="1">130.34 (65.34, 218.29)</td><td align="center" rowspan="1" colspan="1">&#8722;1.19 (&#8722;1.26, &#8722;1.12)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tropical Latin America</td><td align="center" rowspan="1" colspan="1">82&#160;433.87 (41&#160;918.13, 137&#160;283.36)</td><td align="center" rowspan="1" colspan="1">90&#160;680.83 (45&#160;659.38,150&#160;050.8)</td><td align="center" rowspan="1" colspan="1">182.85 (92.06, 306.62)</td><td align="center" rowspan="1" colspan="1">139.67 (71.35, 229.43)</td><td align="center" rowspan="1" colspan="1">&#8722;1.2 (&#8722;1.36, &#8722;1.04)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Latin America</td><td align="center" rowspan="1" colspan="1">88&#160;215.24 (46&#160;299.54, 144&#160;072.71)</td><td align="center" rowspan="1" colspan="1">89&#160;764.2 (44&#160;966.84, 150&#160;400.19)</td><td align="center" rowspan="1" colspan="1">181.98 (93.64, 300.12)</td><td align="center" rowspan="1" colspan="1">120.05 (60.32, 200.84)</td><td align="center" rowspan="1" colspan="1">&#8722;1.3 (&#8722;1.39, &#8722;1.21)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southern Latin America</td><td align="center" rowspan="1" colspan="1">21&#160;125.4 (10&#160;158.08, 36&#160;669.69)</td><td align="center" rowspan="1" colspan="1">24&#160;586.6 (12&#160;235.02, 41&#160;415.95)</td><td align="center" rowspan="1" colspan="1">154.66 (74.21, 268.28)</td><td align="center" rowspan="1" colspan="1">128.51 (64.26, 216.54)</td><td align="center" rowspan="1" colspan="1">&#8722;0.47 (&#8722;0.56, &#8722;0.38)</td></tr><tr><td align="left" rowspan="1" colspan="1">Caribbean</td><td align="center" rowspan="1" colspan="1">18&#160;434.87 (9322.78, 30&#160;460.59)</td><td align="center" rowspan="1" colspan="1">17&#160;085.68 (8494.58, 28&#160;773.17)</td><td align="center" rowspan="1" colspan="1">173.31 (86.57, 288.27)</td><td align="center" rowspan="1" colspan="1">130.23 (65.04, 218.74)</td><td align="center" rowspan="1" colspan="1">&#8722;0.88 (&#8722;0.91, &#8722;0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Europe</td><td align="center" rowspan="1" colspan="1">50&#160;948.64 (26&#160;719.49, 83&#160;359.62)</td><td align="center" rowspan="1" colspan="1">36&#160;129 (18&#160;469.42, 60&#160;454.17)</td><td align="center" rowspan="1" colspan="1">155.28 (82.35, 252.68)</td><td align="center" rowspan="1" colspan="1">140.23 (74.2, 230.17)</td><td align="center" rowspan="1" colspan="1">&#8722;0.23 (&#8722;0.37, &#8722;0.09)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eastern Europe</td><td align="center" rowspan="1" colspan="1">148&#160;323.91 (77&#160;945.08, 242&#160;575.48)</td><td align="center" rowspan="1" colspan="1">117&#160;894.39 (60&#160;182.16, 195&#160;821.6)</td><td align="center" rowspan="1" colspan="1">250.77 (133.85, 407.59)</td><td align="center" rowspan="1" colspan="1">245.6 (130.95, 400.14)</td><td align="center" rowspan="1" colspan="1">0.32 (0.15,0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Asia</td><td align="center" rowspan="1" colspan="1">39&#160;426.46 (21&#160;388.3, 63&#160;492.51)</td><td align="center" rowspan="1" colspan="1">42&#160;300.27 (22&#160;244.37, 68&#160;867.24)</td><td align="center" rowspan="1" colspan="1">204.22 (108.93, 331.43)</td><td align="center" rowspan="1" colspan="1">163.65 (87.02, 265.19)</td><td align="center" rowspan="1" colspan="1">&#8722;0.39 (&#8722;0.57, &#8722;0.21)</td></tr><tr><td align="left" rowspan="1" colspan="1">North Africa and Middle East</td><td align="center" rowspan="1" colspan="1">259&#160;963.65 (135&#160;394.49, 421&#160;780.61)</td><td align="center" rowspan="1" colspan="1">341&#160;353.71 (177&#160;477.33, 560&#160;634.57)</td><td align="center" rowspan="1" colspan="1">283.25 (144.85, 463.72)</td><td align="center" rowspan="1" colspan="1">196.04 (102.21, 321.78)</td><td align="center" rowspan="1" colspan="1">&#8722;1.19 (&#8722;1.29, &#8722;1.09)</td></tr><tr><td align="left" rowspan="1" colspan="1">South Asia</td><td align="center" rowspan="1" colspan="1">801&#160;050.14 (432&#160;071.79, 1&#160;299&#160;042.31)</td><td align="center" rowspan="1" colspan="1">936&#160;793.56 (491&#160;400.06, 1&#160;530&#160;317.1)</td><td align="center" rowspan="1" colspan="1">274.03 (145.06, 448.39)</td><td align="center" rowspan="1" colspan="1">169.55 (88.49, 277.83)</td><td align="center" rowspan="1" colspan="1">&#8722;1.57 (&#8722;1.6, &#8722;1.55)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southeast Asia</td><td align="center" rowspan="1" colspan="1">341&#160;472.08 (182&#160;807.84, 550&#160;563.79)</td><td align="center" rowspan="1" colspan="1">386&#160;144.63 (199&#160;088.06, 628&#160;758.16)</td><td align="center" rowspan="1" colspan="1">250.09 (131.68, 406.46)</td><td align="center" rowspan="1" colspan="1">192.96 (99.97, 313.41)</td><td align="center" rowspan="1" colspan="1">&#8722;0.79 (&#8722;0.82, &#8722;0.76)</td></tr><tr><td align="left" rowspan="1" colspan="1">East Asia</td><td align="center" rowspan="1" colspan="1">704&#160;502.43 (347&#160;104.09, 1&#160;187&#160;985.57)</td><td align="center" rowspan="1" colspan="1">444&#160;699.34 (216&#160;496.14, 747&#160;183.83)</td><td align="center" rowspan="1" colspan="1">189.07 (92.11, 321.13)</td><td align="center" rowspan="1" colspan="1">123.14 (61.32, 204.64)</td><td align="center" rowspan="1" colspan="1">&#8722;1.51 (&#8722;1.68, &#8722;1.34)</td></tr><tr><td align="left" rowspan="1" colspan="1">Oceania</td><td align="center" rowspan="1" colspan="1">5878.65 (3027.84, 9571.11)</td><td align="center" rowspan="1" colspan="1">10&#160;521.9 (5149.62, 17&#160;539.73)</td><td align="center" rowspan="1" colspan="1">333.69 (168.36, 549.05)</td><td align="center" rowspan="1" colspan="1">272.59 (132.38, 455.76)</td><td align="center" rowspan="1" colspan="1">&#8722;0.63 (&#8722;0.65, &#8722;0.61)</td></tr><tr><td align="left" rowspan="1" colspan="1">Western Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">146&#160;209.07 (78&#160;638.01, 234&#160;660.06)</td><td align="center" rowspan="1" colspan="1">272&#160;483.35 (145&#160;767.84, 439&#160;859.43)</td><td align="center" rowspan="1" colspan="1">284.72 (149.5, 463.25)</td><td align="center" rowspan="1" colspan="1">193.71 (101.29, 317.05)</td><td align="center" rowspan="1" colspan="1">&#8722;1.22 (&#8722;1.28, &#8722;1.16)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eastern Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">130&#160;255.89 (69&#160;663.72, 210&#160;496.14)</td><td align="center" rowspan="1" colspan="1">195&#160;550.44 (101&#160;129.3, 319&#160;181.83)</td><td align="center" rowspan="1" colspan="1">256.65 (133.85, 420.64)</td><td align="center" rowspan="1" colspan="1">156.54 (79.18,258.89)</td><td align="center" rowspan="1" colspan="1">&#8722;1.59 (&#8722;1.64, &#8722;1.54)</td></tr><tr><td align="left" rowspan="1" colspan="1">Central Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">41&#160;891.54 (22&#160;349.79, 67&#160;582.28)</td><td align="center" rowspan="1" colspan="1">68&#160;807.4 (35&#160;581.77, 113&#160;066.85)</td><td align="center" rowspan="1" colspan="1">289.34 (150.86, 473.45)</td><td align="center" rowspan="1" colspan="1">182.02 (92.32, 303.02)</td><td align="center" rowspan="1" colspan="1">&#8722;1.42 (&#8722;1.54, &#8722;1.31)</td></tr><tr><td align="left" rowspan="1" colspan="1">Southern Sub-Saharan Africa</td><td align="center" rowspan="1" colspan="1">33&#160;501.18 (17&#160;953.43, 53&#160;949.5)</td><td align="center" rowspan="1" colspan="1">40&#160;505.65 (20&#160;951.67, 66&#160;730.86)</td><td align="center" rowspan="1" colspan="1">215.48 (113.05, 351.33)</td><td align="center" rowspan="1" colspan="1">169.3 (87.58, 279.34)</td><td align="center" rowspan="1" colspan="1">&#8722;0.75 (&#8722;0.77, &#8722;0.72)</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>ASIR, age-standardized incidence rates; EAPC, estimated annual percentage change; SDI, Sociodemographic Index.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Regional level</title><p>There were significant regional differences in endometriosis burden, strongly correlated with SDI levels. Low SDI regions experienced the highest ASPR at 1314 per 100&#160;000 (95% UI: 786.61, 2002.31), whereas high SDI regions displayed the lowest ASPR at 874.89 per 100&#160;000 (95% UI: 545.91, 1307.15) (Table <xref rid="T1" ref-type="table">1</xref> and Figure S1A <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure <xref rid="F1" ref-type="fig">1</xref>A). In these regions, the ASPR decreased from 2022.88 per 100&#160;000 (95% UI: 1224.21, 3077.64) in 1990 to 1314 per 100&#160;000 (95% UI: 786.61, 2002.31) in 2021. Low-middle SDI regions exhibited the greatest decline in ASPR, with an EAPC of &#8722;1.67 (95% CI:&#160;&#8722;1.7,&#160;&#8722;1.64) (Table <xref rid="T1" ref-type="table">1</xref> and Figure S1A <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure <xref rid="F1" ref-type="fig">1</xref>A).</p><p>Regional patterns for ASIR and ASDR were similar. Low SDI regions reported the highest ASIR and ASDR, while high SDI regions had the lowest rate. For example, the ASIR in low SDI regions was 190.36 per 100&#160;000 (95% UI: 98.35, 314.8), compared to 138.51 per 100&#160;000 (95% UI: 70.91, 233.6) in high SDI regions (Table <xref rid="T2" ref-type="table">2</xref> and Figure S1B <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure <xref rid="F1" ref-type="fig">1</xref>B). Likewise, the ASDR in low SDI regions was 120.08 per 100,000 (95% UI: 62.99, 200.07), versus 80.58 per 100,000 (95% UI: 43.37, 134.5) in high SDI regions (Table S1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link> and Figure S1C <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure <xref rid="F1" ref-type="fig">1</xref>C). Together, these findings highlighted the complex relationship between sociodemographic status and endometriosis burden. While high SDI regions have made significant progress in reducing the prevalence and impact of endometriosis, low SDI regions still face significant challenges.</p><p>ASPR declined in most regions but increased in Eastern Europe, with an EAPC of 0.32 (95% CI: 0.15, 0.5). High-income North America experienced the largest decline in ASPR, reaching 609.96 per 100&#160;000 (95% UI: 381.66, 902.65) in 2021, and the EAPC was &#8722;1.91 (95% CI:&#160;&#8722;2.08,&#160;&#8722;1.75), followed by South Asia with an EAPC of &#8722;1.77 (95% CI:&#160;&#8722;1.8,&#160;&#8722;1.74). Oceania demonstrated the highest ASPR, with 1832.2 per 100&#160;000 (95% UI: 1066.77, 2790.6), followed by Eastern Europe, with 1585.38 per 100&#160;000 (95% UI: 977.34, 2415.93) (Table <xref rid="T1" ref-type="table">1</xref>, Figure S1A <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). Oceania and Eastern Europe also had the highest ASIR. Specifically, Oceania reported an ASIR of 272.59 per 100&#160;000 (95% UI: 132.38, 455.76), while Eastern Europe had an ASIR of 245.6 per 100&#160;000 (95% UI: 130.95, 400.14) . In contrast, High-income North America exhibited the lowest ASIR at 99.5 per 100&#160;000 (95% UI: 49.71, 167.14) and highest decline with EAPC of &#8722;2.07 (95% CI:&#160;&#8722;2.24,&#160;&#8722;1.9). Only Eastern Europe and Western Europe experienced an increase in ASIR, with an EAPC of 0.32 (95% CI: 0.15, 0.5) and 0.02 (95% CI:&#160;&#8722;0.02, 0.07), respectively (Table <xref rid="T2" ref-type="table">2</xref>, Figure S1B <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). From 1990 to 2021, the ASDR decreased the most in high-income North America (EAPC:&#160;&#8722;1.92, 95% CI:&#160;&#8722;&#160;2.08,&#160;&#8722;1.76) and the least in Western Europe (EAPC &#8722;0.08, 95% CI:&#160;&#8722;0.1,&#160;&#8722;0.05). Eastern Europe was the only region with an increasing ASDR, with an EAPC of 0.33 (95% CI: 0.15, 0.5). In 2021, Oceania and Eastern Europe had the highest ASDR at 168.52 (95% UI: 84.58, 290.53) and 146.28 (95% UI: 78.19, 245.1) per 100&#160;000 (Table S1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>, Figure S1C <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>).</p></sec><sec><title>Country level</title><p>The ASPR of endometriosis among 204 countries varied from 518.54 to 2383.43 per 100&#160;000. Niger (2383.43 per 100&#160;000; 95% UI: 1393.25, 3600.93), Chad (1992.29 per 100&#160;000; 95% UI: 1155.19, 3030.03), and Solomon Islands (1985.24 per 100&#160;000; 95% UI: 1153.28, 3015.55) exhibited the highest ASPR. Notably, two of these countries are in Africa (Niger and Chad), and one is in Oceania (Solomon Islands). The largest decrease in ASPR from 1990 to 2021 was observed in Yemen. Seventeen countries experienced an increase in ASPR, among which, Iceland stood out with the highest EAPC of 1.21 (95% CI: 0.93, 1.48) (Table S2 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). Solomon Islands had the highest ASIR (285.04 per 100&#160;000; 95% UI: 139.87, 475.66), while Iceland had the lowest rate (79.09 per 100&#160;000; 95% UI: 36.84, 147.04). The wide range of incidence rate indicates that risk factors, healthcare systems, and prevention strategies vary between countries. Seventeen countries experienced an increase in ASIR, again, Iceland was the most prominent, with an EAPC of 2.4 (95% CI: 2.02, 2.78) (Table S2 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). In 2021, India had the highest DALYs due to endometriosis, with 392&#160;961.05 (95% UI: 208 162.52, 661 651.09), and Niger displayed the highest ASDR at 218.81 per 100&#160;000 (95% UI: 109.26, 366.38). Solomon Islands ranked second in ASDR (182.53 per 100&#160;000; 95% UI: 91.42, 315.46), and China ranked second in DALYs with 269&#160;427.74 (95% UI: 142&#160;542.44, 455&#160;047.13). The ASDR decreased the most from 1990 to 2021 in Yemen (EAPC &#8722;2.83, 95% CI:&#160;&#8722;3.02,&#160;&#8722;2.63), Nepal (EAPC &#8722;2.62, 95% CI:&#160;&#8722;2.73, 2.5.), and Equatorial Guinea (EAPC &#8722;2.56, 95% CI:&#160;&#8722;2.64, &#8722;2.48). Seventeen countries experienced an increase in ASDR, Iceland again had the largest rise, with an EAPC of 1.21 (95% CI: 0.93, 1.48) (Table S2 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). The consistency between national and regional patterns highlightes the significant challenges posed by endometriosis in parts of Oceania and Africa, impacting both prevalence and overall health-related quality of life in those populations.</p></sec><sec><title>Age patterns</title><p>The age distribution of endometriosis metrics (prevalence, incidence, and DALYs) was largely consistent across different SDI regions. Both prevalence and DALYs rates peaked at 25&#8211;29 year age group, with a slight secondary increase at 40&#8211;44&#160;years. By contrast, the incidence was highest in the 20&#8211;24 year age group, then declined through ages 30&#8211;34 years, followed by a second small peak at 40&#8211;44 years, and finally a significant decline after 45 years (Table S3 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). These patterns suggest that the greatest burdens of endometriosis falls in women aged 25&#8211;29&#160;years. From 1990 to 2021, prevalence, incidence and DALYs rates declined across all age groups. Throughout this period, women aged 25&#8211;29&#160;years maintained the highest prevalence and DALY rates, while women aged 20&#8211;24&#160;years consistently had the highest incidence rates (Figure <xref rid="F2" ref-type="fig">2</xref>D-F, Table S4-6 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>).<fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>The rate of prevalence (A), incidence (B), and DALYs (C) of endometriosis in 1990 and 2021 at different age, and the rate of prevalence (D), incidence (E), and DALYs (F) of endometriosis over time by age category..</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-5927-g002.jpg"/></fig>
</p></sec><sec><title>Decomposition analysis</title><p>The incidence, prevalence and DALYs of endometriosis attributable to aging, population and epidemiologic change were analyzed by decomposition analysis at the global level. Subgroup analyses were performed across five SDI strata and 21 regions, encompassing a total of 27 individual areas. Globally, population growth accounted for a 364.86% change for prevalence, followed by epidemiologic change (&#8722;274.67%) and aging (9.81%). Similarly, population growth alone would account for 1211.68% of the incidence change and 366.99% of the DALYs change (Figure <xref rid="F3" ref-type="fig">3</xref>, Table S7 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). In low SDI regions, population growth was an overwhelming driver of prevalence change (200.93%), whereas epidemiological change contributed &#8722;100.89% and aging contributed &#8722;0.03%. In low-middle SDI regions, population growth was the largest contributor to changes in prevalence and DALYs, while in high and high-middle SDI regions, most of the change was due to epidemiological improvements. Population and epidemiological change also substantially influenced changes in prevalence, incidence, and DALYs in South Asia (Figure <xref rid="F3" ref-type="fig">3</xref>, Table S7 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>).<fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>Change in prevalence (A), incidence (B), and DALYs (C) of endometriosis decomposed by three population-level determinants: aging, population and epidemiological change at the global level, five regions, and and 21 GBD regions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-5927-g003.jpg"/></fig>
</p></sec><sec><title>Cross-country health inequality analysis</title><p>These findings reveal significant inequalities in endometriosis burden between higher- and lower-SDI regions, in both absolute and relative terms. The concentration index of prevalence improved from &#8722;0.12 (95% CI:&#160;&#8722;0.13,&#160;&#8722;0.1) in 1990 to &#8722;0.07 (95% CI:&#160;&#8722;0.09,&#160;&#8722;0.05) in 2021 (Figure <xref rid="F4" ref-type="fig">4</xref>A). Consistently, the SII for prevalence between high and low SDI regions narrowed from &#8722;948 in 1990 to &#8722;276 in 2021 (Figure <xref rid="F4" ref-type="fig">4</xref>B). Similarly, the concentration index for incidence improved from &#8722;0.1 (95% CI:&#160;&#8722;0.11,&#160;&#8722;0.08) in 1990 to &#8722;0.06 (95% CI:&#160;&#8722;0.07,&#160;&#8722;0.04) in 2021 (Figure <xref rid="F4" ref-type="fig">4</xref>C), and the SII improved from &#8722;133 to &#8722;36 (Figure <xref rid="F4" ref-type="fig">4</xref>D). For DALYs, the concentration index went from &#8722;0.11 (95% CI:&#160;&#8722;0.13,&#160;&#8722;0.09) to &#8722;0.07 (95% CI:&#160;&#8722;0.09, &#8722;0.05) (Figure <xref rid="F4" ref-type="fig">4</xref>E), and the SII of DALYs improved from &#8722;85 to &#8722;25 (Figure <xref rid="F4" ref-type="fig">4</xref>F). These results demonstrate a reduction in the inequality of endometriosis burden over time.<fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><p>Health inequality regression curves and concentration curves for the prevalence (A&#8211;B), incidence (C&#8211;D), and DALYs (E&#8211;F) of endometriosis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-5927-g004.jpg"/></fig>
</p></sec><sec><title>Trend of endometriosis from 2022 to 2040</title><p>The burden of endometriosis is projected to change significantly from 2021 to 2040. The global ASPR is also projected to decline, from 1023.8 per 100&#160;000 (95% CI: 1023.38, 1024.23) in 2021 to 887.89 per 100&#160;000 (95% CI: 530.79, 1245) by 2040 (Figure <xref rid="F5" ref-type="fig">5</xref>A, Table S8 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>)Th.e ASIR is expected to decrease globally from 162.71 per 100&#160;000 (95% CI: 162.54, 162.88) in 2021 to 142.13 per 100&#160;000 (95% CI: 77.93, 206.33) by 2040, representing a 12.65% decrease (Figure <xref rid="F5" ref-type="fig">5</xref>B, Table S8 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>). Finally, the ASDR is forecast to decrease from 94.25 per 100&#160;000 (95% CI: 94.12, 94.38) in 2021 to 80.03 per 100&#160;000 (95% CI: 47.59, 112.47) by 2040 (Figure <xref rid="F5" ref-type="fig">5</xref>C, Table S8 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E821" ext-link-type="uri">http://links.lww.com/JS9/E821</ext-link>).<fig position="float" id="F5" orientation="portrait"><label>Figure 5.</label><caption><p>Trend in ASPR (A), ASIR (B), and ASDR (C) of endometriosis from 2022 to 2040. The purple line represents the predicted trend, and the gray-shaded area represents the 95% CI of the predicted values; the gray-dotted vertical line divides the data into real values (1990&#8211;2021) and predicted values (2022&#8211;2040).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-5927-g005.jpg"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our comprehensive analysis of endometriosis burden from 1990 to 2021 reveals a complex pattern of disparities and trends across regions and SDI levels. Globally, disease burden of endometriosis declined over this period. The burden varied across income levels and was inversely related to income level. Correspondingly, health inequalities among the relevant population have improved. Population growth and epidemiological change were identified as the two major drivers of changes in prevalence, incidence and DALYs. Notably, women aged 25&#8211;29&#160;years emerged as a particularly affected group, underscoring the necessity for early screening and diagnose, as well as early laparoscopic interventions that preserve fertility and protect nerve function in this age group. Overall, this study highlights the global health impact of endometriosis and provides a critical foundation for developing prevention and management strategies, such as targeted surgical resource planning, tiered intervention strategies in low-resource settings, and the development of cost-effective prevention and management methods.</p><p>Our observed decreasing trends are consistent with previous GBD studies, which also reported declines in age-standardized rates of endometriosis over time<sup>[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R20" ref-type="bibr">20</xref>]</sup>, reflecting significant advances in women&#8217;s health in recent decades. One example of progress is the the National Action Plan for Endometriosis (NAPE), launched in 2018 to improve patients&#8217; outcomes via increased awareness and education, better clinical management, and research[<xref rid="R40" ref-type="bibr">40</xref>]. Similarly, the 2021 WHO Endometriosis Fact Sheet was a welcome step toward raising the global awareness of the disease. The success of NAPE, along with other global efforts, has contributed to significant reductions in the prevalence and incidence rate, especially in low-income regions with a heavy endometriosis burden[<xref rid="R41" ref-type="bibr">41</xref>]. Nevertheless, high SDI regions still show the lowest ASPR, ASIR and ASDR while low SDI regions have the highest rates, indicating the persistent socioeconomic disparities in the global burden of endometriosis. This disparity likely results from a combination of factors, including healthcare access, public health systems, and geographical, cultural, and socioeconomic differences, as well as environmental and genetic issues[<xref rid="R3" ref-type="bibr">3</xref>]. The diagnosis of endometriosis typically relies on imaging (e.g., transvaginal ultrasound and magnetic resonance imaging) or laparoscopic examination[<xref rid="R42" ref-type="bibr">42</xref>], which are often scarce or unevenly distributed in low SDI regions. Additionally, the lack of specialized doctors and surgical equipment in low SDI areas makes it difficult for patients to access effective treatment, thereby increasing the burden, especially the DALYs[<xref rid="R43" ref-type="bibr">43</xref>]. The etiologies of endometriosis are complex, for example, prenatal exposure to diethylstilbestrol[<xref rid="R44" ref-type="bibr">44</xref>], low birthweight[<xref rid="R45" ref-type="bibr">45</xref>], lean childhood body size[<xref rid="R46" ref-type="bibr">46</xref>], low body mass index, and waist-to-hip ratio<sup>[<xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref>]</sup> have all been associated with a higher incidence of endometriosis. These risk factors are more common in low SDI populations. Women in low SDI regions may face more severe environmental pollution issues, and environmental pollutants such as dioxins and polychlorinated biphenyls are considered potential risk factors for endometriosis[<xref rid="R48" ref-type="bibr">48</xref>]. In low SDI regions, poor dietary habits (such as high-fat, low-fiber diets) and malnutrition[<xref rid="R49" ref-type="bibr">49</xref>], coupled with a higher likelihood of prolonged exposure to pesticides, chemicals, or other harmful substances[<xref rid="R50" ref-type="bibr">50</xref>], thereby increasing the risk of developing the disease. Certain genetic variants may also elevate the risk of endometriosis[<xref rid="R51" ref-type="bibr">51</xref>], and the distribution of these genetic variants may vary among different populations. Additionally, the impact of genetic factors may be mitigated by better medical management and environmental conditions[<xref rid="R52" ref-type="bibr">52</xref>]. Indeed, the prevalence rates in low SDI regions may even be underestimated, socioeconomic barriers, lack of awareness, insufficient medical resources, and inadequate provider training all contribute to diagnostic delays and missed diagnoses<sup>[<xref rid="R53" ref-type="bibr">53</xref>,<xref rid="R54" ref-type="bibr">54</xref>]</sup>. The persistently high burden in low SDI regions warrants further consideration. Implementing measures such as primary healthcare training programs, public health education campaigns, and accessible non-invasive diagnostic facilities may substantially mitigate these issue. In contrast, high SDI regions benefit from stronger healthcare systems and effective public health interventions, which likely reduce the endometriosis burden. The exceptionally high prevalence and incidence rates observed in Oceania and Eastern Europe might due to a combination of socioeconomic factors, ethnicity, and education level differences<sup>[<xref rid="R55" ref-type="bibr">55</xref>-<xref rid="R57" ref-type="bibr">57</xref>]</sup>. These regions urgently need targeted public health policies to raise awareness, implement multidisciplinary care (such as postoperative follow-up, psychological and social support), and invest in research into etiology, biomarker discovery, and effective treatment.</p><p>Laparoscopic surgery holds an irreplaceable and critical position in the diagnostic and therapeutic system for endometriosis. As the clinical diagnostic gold standard, laparoscopic technology enables precise visual assessment of pelvic lesions, comprehensively reflecting the anatomical distribution and severity of the disease[<xref rid="R58" ref-type="bibr">58</xref>]. In terms of treatment, laparoscopic surgery effectively alleviates pain symptoms and improves reproductive outcomes through accurate excision or ablation of ectopic lesions[<xref rid="R59" ref-type="bibr">59</xref>]. Its unique minimally invasive advantages facilitate meticulous dissection of pelvic adhesions and restoration of normal anatomical relationships, thereby significantly reducing the risk of disease recurrence. However, the clinical efficacy of this technique is strongly correlated with the surgeon&#8217;s experience[<xref rid="R60" ref-type="bibr">60</xref>] and exhibits notable regional disparities. High and middle SDI regions demonstrate higher adoption rates of laparoscopic surgery, whereas low SDI regions face diagnostic and therapeutic challenges[<xref rid="R61" ref-type="bibr">61</xref>], primarily due to limited healthcare resource allocation and technical accessibility barriers[<xref rid="R62" ref-type="bibr">62</xref>]. Notably, there is no unified standard for surgical approaches (e.g., extent of resection, application of specific techniques) across regions with varying development levels. High SDI regions have progressively incorporated ultrasound-based preoperative staging systems to assess surgical complexity[<xref rid="R63" ref-type="bibr">63</xref>] and adopted advanced technologies such as robot-assisted laparoscopy. In contrast, middle and low SDI regions still rely predominantly on conventional laparoscopic techniques[<xref rid="R64" ref-type="bibr">64</xref>].This regional disparity underscores the necessity for stratified diagnostic and therapeutic strategies. In low SDI regions, a three-tier intervention strategy is recommended. First, establish resource allocation optimization mechanisms; second, improve community hospital-based early screening systems; and finally, implement comprehensive measures including establishing specialized treatment centers, developing tiered physician training programs, and creating digital remote mentoring platforms to systematically enhance laparoscopic surgical skills for endometriosis. International collaborations (e.g., initiatives by the International Federation of Gynecology and Obstetrics) can provide support through donated second-hand equipment and training programs. Additionally, promoting cost-effective techniques such as traditional laparoscopic electrocoagulation combined with blunt dissection, reducing reliance on high-cost consumables[<xref rid="R65" ref-type="bibr">65</xref>], may serve as a feasible solution for resource-limited settings. Given the burden in women aged 25&#8211;29, surgeons should prioritize fertility-preserving and nerve-sparing techniques, actively promote the widespread adoption of these procedures, and explore novel surgical approaches[<xref rid="R66" ref-type="bibr">66</xref>].</p><p>To elucidate the underlying factors contributing to the evolving disease burden of endometriosis from 1990 to 2021, the study conducted decomposition analysis based aging, population growth and epidemiological changes. The results revealed that population expansion and epidemiologic change significantly influenced the variations in prevalence, incidence and DALYs of endometriosis across different SDI region. Specifically, the global population growth has been identified as a primary driver of increased disease burden. Conversely, the epidemiological change have demonstrated a mitigating effect on the global burden of endometriosis, as evidenced by reductions in prevalence, incidence and DALYs. This positive trend suggests that public health initiatives and medical interventions are yielding measurable progress. However, it is noteworthy that while epidemiological changes have reduced the burden both globally and within all five SDI regions, these improvements have been substantially counterbalanced by population growth. To effectively manage and control the disease burden of endometriosis, it is imperative to develop strategies that optimize the allocation and utilization of public health resources, particularly in the context of ongoing population growth.</p><p>Few studies have investigated the incidence and prevalence of endometriosis in adolescents. One study found that among adolescents with pelvic pain, the prevalence of visually confirmed endometriosis (via laparoscopy) ranged from 25% to 100%. On average, about 49% of adolescents with chronic pelvic pain and 75% of those with pain unresponsive to medication were diagnosed with endometriosis[<xref rid="R67" ref-type="bibr">67</xref>]. Similarly, nearly two-thirds of adolescents with chronic non-cyclic pelvic pain were found to have endometriosis upon laparoscopy[<xref rid="R67" ref-type="bibr">67</xref>]. In our data, the peak prevalence and DALYs rates of endometriosis occurred in 25&#8211;29 year age group, whereas the highest incidence rate was in the 20&#8211;24 year group,. This disparity might be explained by an average diagnostic delays of 3&#8211;10&#160;years for endometriosis[<xref rid="R2" ref-type="bibr">2</xref>]. One major reason for diagnostic delay is that laparoscopic surgery with biopsy has long been the gold standard, and its accuracy depends greatly on the surgeon&#8217;s skill and interest in detecting endometriosis<sup>[<xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R68" ref-type="bibr">68</xref>]</sup>. In addition, many women hesitate to report symptoms due to embarrassment or the mistaken belief that their pain is &#8220;normal,&#8221; which further delays seeking medical attention<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R69" ref-type="bibr">69</xref>]</sup>. Encouragingly, non-invasive diagnosis based on imaging technologies has improved the detection rate of endometriosis<sup>[<xref rid="R70" ref-type="bibr">70</xref>,<xref rid="R71" ref-type="bibr">71</xref>]</sup>, which is now recommended by clinical guidances[<xref rid="R72" ref-type="bibr">72</xref>]. Reportedly, the median age at symptom onset for endometriosis is 25&#160;years, and the median age at diagnosis is 26&#160;years[<xref rid="R73" ref-type="bibr">73</xref>], which is broadly consistent with our findings. However, other studies have reported different results. For example, the peak age at first diagnosis or suspicion of endometriosis was 30&#8211;34&#160;years in Australian[<xref rid="R74" ref-type="bibr">74</xref>]. The highest prevalence rate was reported in the 35&#8211;44&#8201;year age group in Spain[<xref rid="R75" ref-type="bibr">75</xref>] and in the 36&#8211;45 year group in the USA[<xref rid="R76" ref-type="bibr">76</xref>]. Additionally, one study reported that the incidence rates declined over time in all age groups except those aged 26&#8211;30 and 56&#8211;60 years[<xref rid="R76" ref-type="bibr">76</xref>], a pattern inconsistent with our findings. Collectively, these observations reflect regional differences in the epidemiology of endometriosis, and reinforce that women aged 25&#8211;29&#160;years merit particular attention in monitoring and management efforts. Patients with endometriosis frequently suffer from psychological conditions such as anxiety and depression[<xref rid="R8" ref-type="bibr">8</xref>], particularly women aged 25-29, who face significant fertility pressures and societal expectations, exacerbating their mental health challenges. The chronic pelvic pain associated with endometriosis severely impair women&#8217;s work capacity and productivity[<xref rid="R77" ref-type="bibr">77</xref>]. Given that women in this age group are at a pivotal stage of career development, the disease can have long-term consequences on their professional trajectories. Moreover, endometriosis is a leading cause of infertility[<xref rid="R5" ref-type="bibr">5</xref>], and women aged 25&#8211;29 years are in their prime reproductive years. The condition&#8217;s impact on their fertility may further contribute to declining birth rates. Therefore, it is imperative for the government to enhance policy advocacy to raise awareness of endometriosis among both the public and healthcare providers. Targeted preoperative screening (e.g., symptom checklists and imaging), standardized pain and fertility questionnaires should be incorporated into pre-pregnancy healthcare services for women in the most affected age groups to facilitate timely detection and treatment of endometriosis. Additionally, reproductive health education and counseling should be promoted to help patients better understand the disease&#8217;s implications for fertility and the available management options.</p><p>Despite the downward trend in endometriosis incidence and projections of further decline by 2040, the overall disease burden of endometriosis remains very high. Therefore, greater emphasis should be placed on the prevention, monitoring, diagnosis and treatment of endometriosis. As endometriosis is progressive, early diagnosis and treatment are particularly important for younger patients<sup>[<xref rid="R78" ref-type="bibr">78</xref>,<xref rid="R79" ref-type="bibr">79</xref>]</sup>. Endometriosis is also a leading cause of disability and reduced quality of life in women of reproductive age[<xref rid="R43" ref-type="bibr">43</xref>], underlining the need for timely intervention. In addition, delayed diagnosis can lead to central sensitization, chronic pain, and scarring<sup>[<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R80" ref-type="bibr">80</xref>]</sup>. Unfortunately, a lack of awareness about menstrual health and endometriosis among healthcare providers remains widespread. Educating both medical professionals and patients and their caregivers about what constitutes abnormal pelvic pain in adolescence is indispensable for promoting appropriate care-seeking behavior and reducing diagnostic delays in endometriosis<sup>[<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R81" ref-type="bibr">81</xref>,<xref rid="R82" ref-type="bibr">82</xref>]</sup>.</p><p>Our study has several advantages. First, to our knowledge, it is the first to analyze endometriosis burden by using cross-country inequality and decomposition analysis, which helped identify areas require greater attention and resources, and can guide optimal care allocation globally. Second, we utilized the newly released GBD 2021 dataset, which has a robust design, a large sample size, and sophisticated statistical methodology. Third, for the first time, we performed a detailed age-subgroup analysis of endometriosis burden for the first time, providing policymakers insight into which age groups to focus on.</p><p>However, there are still several limitations. First, the estimates of endometriosis in the GBD data may be influenced by multiple factors: the lack of unified diagnostic criteria globally, regional variations in disease coding systems, and inadequate medical surveillance systems, particularly in resource-limited settings, all of which contribute to case underestimation and reporting bias. Second, clinical diagnosis is challenging due to its diverse and atypical symptomatology, making traditional diagnostic approaches based on medical history and physical examination prone to misdiagnosis or missed diagnosis. Third, since GBD 2021 dose not provide data on the risk factors of endometriosis, so we could not assess the impact of relevant risk factors or adjust for potential confounding variables such as healthcare accessibility and socioeconomic status in our analysis. It is important to note that the GBD modeling methodology has inherent limitations. The accuracy of its estimates heavily depends on the availability and quality of primary data, yet there are substantial disparities in basic healthcare data collection capabilities across countries, particularly affecting low- and middle-income nations. Specifically, in regions with underdeveloped healthcare infrastructure and insufficient policy frameworks, the true incidence rates of endometriosis are likely to be substantially underestimated. Conversely, in some countries, the epidemiological data may present an overestimated disease burden, primarily due to the disproportionate reliance on data collected from major urban centers, which may not accurately represent the national disease profile[<xref rid="R83" ref-type="bibr">83</xref>]. Such data disparities may affect the accuracy and generalizability of our finding. Furthermore, our predictive model is based on historical APC trends and assumes constant healthcare conditions, diagnostic criteria, and public health policies. However, in reality, rapid advancements in diagnostic and surgical technologies, as well as evolving public health policies, may cause actual epidemiological patterns to deviate from current projections. These factors must be carefully considered when interpreting the results.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In summary, our study shows that although ASPR, ASIR, and ASDR for endometriosis declined from 1990 to 2021, significant inequalities persist at global and regional levels. Countries with lower SDI experience a greater burden of endometriosis. In these countries, timely and effective prevention and management strategies are needed to improve global health outcomes. Internationally, it is critical to promote economic development in low-SDI countries, and for high-income regions to share advanced medical technologies and expertise to improve health outcomes. Additionally, more attention should be paid to the monitoring and management of endometriosis in women aged 25&#8211;29&#160;years.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors thank the GBD team for allowing us to access the comprehensive database.</p></ack><fn-group><fn id="FT0001"><label>
<sup>#</sup>
</label><p>These authors contributed equally to this study.</p></fn><fn fn-type="other"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal&#8217;s website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.lww.com/international-journal-of-surgery" ext-link-type="uri">www.lww.com/international-journal-of-surgery.</ext-link></p></fn><fn fn-type="equal"><p>Published online 17 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>Not applicable.</p></sec><sec><title>Consent</title><p>Not applicable.</p></sec><sec><title>Sources of funding</title><p>This work was supported by the National Natural Science Foundation of China (No. 82101749), Hubei Provincial Natural Science Foundation of China (2025AFB764), Fundamental Research Funds for the Central Universities (2042025YXB024), and Funding from the National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital) (No. BYSYSZKF2023021).</p></sec><sec><title>Author contributions</title><p>D.J.L., Z.Y., and Y.C.G. designed the study. X.S.F. and Z.Y. collected the data, X.S.F., H.Q., Y.P., and Z.Y. analyzed the data. X.S.F., Y.P., and H.Q. drafted the manuscript. Z.Y., D.J.L., and Y.C.G. revised the manuscript. All authors approved the final manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare no potential conflicts of interest with respect to research, authorship, and/or publication of this article.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>Not applicable.</p></sec><sec><title>Guarantor</title><p>Jinli Ding.</p></sec><sec><title>Provenance and peer review</title><p>Not commissioned, externally peer-reviewed.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>The datasets analyzed are available in the GBD 2021.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kotlyar</surname><given-names>AM</given-names></name><name name-style="western"><surname>Flores</surname><given-names>VA</given-names></name></person-group>. <article-title>Endometriosis is a chronic systemic disease: clinical challenges and novel innovations</article-title>. <source>Lancet</source><year>2021</year>;<volume>397</volume>:<fpage>839</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">33640070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(21)00389-5</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nnoaham</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hummelshoj</surname><given-names>L</given-names></name><name name-style="western"><surname>Webster</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>World endometriosis research foundation global study of women&#8217;s health, c. reprint of: impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries</article-title>. <source>Fertil Steril</source><year>2019</year>;<volume>112</volume>:<fpage>e137</fpage>&#8211;<lpage>e152</lpage>.<pub-id pub-id-type="pmid">31623725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2019.08.082</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shafrir</surname><given-names>AL</given-names></name><name name-style="western"><surname>Farland</surname><given-names>LV</given-names></name><name name-style="western"><surname>Shah</surname><given-names>DK</given-names></name><etal/></person-group>. <article-title>Risk for and consequences of endometriosis: a critical epidemiologic review</article-title>. <source>Best Pract Res Clin Obstet Gynaecol</source><year>2018</year>;<volume>51</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">30017581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bpobgyn.2018.06.001</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>SK</given-names></name><name name-style="western"><surname>Chapron</surname><given-names>C</given-names></name><name name-style="western"><surname>Giudice</surname><given-names>LC</given-names></name><etal/></person-group>. <article-title>Clinical diagnosis of endometriosis: a call to action</article-title>. <source>Am J Obstet Gynecol</source><year>2019</year>;<volume>220</volume>:<fpage>354e351</fpage>&#8211;<lpage>354e312</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2018.12.039</pub-id><pub-id pub-id-type="pmid">30625295</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Healy</surname><given-names>DL</given-names></name><name name-style="western"><surname>Trounson</surname><given-names>AO</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>AN</given-names></name></person-group>. <article-title>Female infertility: causes and treatment</article-title>. <source>Lancet</source><year>1994</year>;<volume>343</volume>:<fpage>1539</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="pmid">7911874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(94)92941-6</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Forno</surname><given-names>S</given-names></name><name name-style="western"><surname>Raspollini</surname><given-names>A</given-names></name><name name-style="western"><surname>Doglioli</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Painful sexual intercourse, quality of life and sexual function in patients with endometriosis: not just deep dyspareunia</article-title>. <source>Arch Gynecol Obstet</source><year>2024</year>;<volume>310</volume>:<fpage>2091</fpage>&#8211;<lpage>100</lpage>.<pub-id pub-id-type="pmid">39052076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00404-024-07643-7</pub-id><pub-id pub-id-type="pmcid">PMC11392973</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farland</surname><given-names>LV</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>J</given-names></name><name name-style="western"><surname>Sasamoto</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Endometriosis and risk of adverse pregnancy outcomes</article-title>. <source>Obstet Gynecol</source><year>2019</year>;<volume>134</volume>:<fpage>527</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">31403584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000003410</pub-id><pub-id pub-id-type="pmcid">PMC6922084</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aubry</surname><given-names>G</given-names></name><name name-style="western"><surname>Panel</surname><given-names>P</given-names></name><name name-style="western"><surname>Thiollier</surname><given-names>G</given-names></name><name name-style="western"><surname>Huchon</surname><given-names>C</given-names></name><name name-style="western"><surname>Fauconnier</surname><given-names>A</given-names></name></person-group>. <article-title>Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the endometriosis health profile-5 (EHP-5) and the EuroQol-5D (EQ-5D)</article-title>. <source>Hum Reprod</source><year>2017</year>;<volume>32</volume>:<fpage>1258</fpage>&#8211;<lpage>69</lpage>.<pub-id pub-id-type="pmid">28383700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/dex057</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shigesi</surname><given-names>N</given-names></name><name name-style="western"><surname>Kvaskoff</surname><given-names>M</given-names></name><name name-style="western"><surname>Kirtley</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis</article-title>. <source>Hum Reprod Update</source><year>2019</year>;<volume>25</volume>:<fpage>486</fpage>&#8211;<lpage>503</lpage>.<pub-id pub-id-type="pmid">31260048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humupd/dmz014</pub-id><pub-id pub-id-type="pmcid">PMC6601386</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>JA</given-names></name><name name-style="western"><surname>Missmer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Vitonis</surname><given-names>AF</given-names></name><name name-style="western"><surname>Sarda</surname><given-names>V</given-names></name><name name-style="western"><surname>Laufer</surname><given-names>MR</given-names></name><name name-style="western"><surname>DiVasta</surname><given-names>AD</given-names></name></person-group>. <article-title>Prevalence of migraines in adolescents with endometriosis</article-title>. <source>Fertil Steril</source><year>2018</year>;<volume>109</volume>:<fpage>685</fpage>&#8211;<lpage>90</lpage>.<pub-id pub-id-type="pmid">29605402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2017.12.016</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Farland</surname><given-names>LV</given-names></name><name name-style="western"><surname>Yan</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Endometriosis typology and ovarian cancer risk</article-title>. <source>Jama</source><year>2024</year>;<volume>332</volume>:<fpage>482</fpage>&#8211;<lpage>89</lpage>.<pub-id pub-id-type="pmid">39018030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2024.9210</pub-id><pub-id pub-id-type="pmcid">PMC11255975</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kvaskoff</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahamat-Saleh</surname><given-names>Y</given-names></name><name name-style="western"><surname>Farland</surname><given-names>LV</given-names></name><etal/></person-group>. <article-title>Endometriosis and cancer: a systematic review and meta-analysis</article-title>. <source>Hum Reprod Update</source><year>2021</year>;<volume>27</volume>:<fpage>393</fpage>&#8211;<lpage>420</lpage>.<pub-id pub-id-type="pmid">33202017</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humupd/dmaa045</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>As-Sanie</surname><given-names>S</given-names></name><name name-style="western"><surname>Black</surname><given-names>R</given-names></name><name name-style="western"><surname>Giudice</surname><given-names>LC</given-names></name><etal/></person-group>. <article-title>Assessing research gaps and unmet needs in endometriosis</article-title>. <source>Am J Obstet Gynecol</source><year>2019</year>;<volume>221</volume>:<fpage>86</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="pmid">30790565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2019.02.033</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Missmer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Tu</surname><given-names>FF</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>SK</given-names></name><etal/></person-group>. <article-title>Impact of endometriosis on life-course potential: a narrative review</article-title>. <source>Int J Gen Med</source><year>2021</year>;<volume>14</volume>:<fpage>9</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">33442286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJGM.S261139</pub-id><pub-id pub-id-type="pmcid">PMC7800443</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Leng</surname><given-names>J</given-names></name></person-group>. <article-title>A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update</article-title>. <source>Reprod Health</source><year>2018</year>;<volume>15</volume>:<fpage>82</fpage>.<pub-id pub-id-type="pmid">29783992</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12978-018-0506-7</pub-id><pub-id pub-id-type="pmcid">PMC5963030</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simoens</surname><given-names>S</given-names></name><name name-style="western"><surname>Dunselman</surname><given-names>G</given-names></name><name name-style="western"><surname>Dirksen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres</article-title>. <source>Hum Reprod</source><year>2012</year>;<volume>27</volume>:<fpage>1292</fpage>&#8211;<lpage>99</lpage>.<pub-id pub-id-type="pmid">22422778</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/des073</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soliman</surname><given-names>AM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Du</surname><given-names>EX</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>C</given-names></name><name name-style="western"><surname>Winkel</surname><given-names>C</given-names></name></person-group>. <article-title>The direct and indirect costs associated with endometriosis: a systematic literature review</article-title>. <source>Hum Reprod</source><year>2016</year>;<volume>31</volume>:<fpage>712</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">26851604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/dev335</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>TT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>QJ</given-names></name></person-group>. <article-title>Global, regional, and national endometriosis trends from 1990 to 2017</article-title>. <source>Ann N Y Acad Sci</source><year>2021</year>;<volume>1484</volume>:<fpage>90</fpage>&#8211;<lpage>101</lpage>.<pub-id pub-id-type="pmid">32909625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/nyas.14468</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liao</surname><given-names>K</given-names></name><name name-style="western"><surname>Luo</surname><given-names>B</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name></person-group>. <article-title>The burden of endometriosis in China from 1990 to 2019</article-title>. <source>Front Endocrinol (Lausanne)</source><year>2022</year>;<volume>13</volume>:<fpage>935931</fpage>.<pub-id pub-id-type="pmid">36051388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2022.935931</pub-id><pub-id pub-id-type="pmcid">PMC9424490</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J</given-names></name></person-group>. <article-title>Global Burden of Endometriosis in 204 Countries and Territories from 1990 to 2019</article-title>. <source>Clin Exp Obstet Gynecol</source><year>2022</year>;<volume>49</volume>:<fpage>235</fpage>.</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CJL</given-names></name></person-group>. <article-title>Findings from the global burden of disease study 2021</article-title>. <source>Lancet</source><year>2024</year>;<volume>403</volume>:<fpage>2259</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">38762327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(24)00769-4</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>R</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence</article-title>. <source>Prem J Sci</source><year>2025</year>. doi:<pub-id pub-id-type="doi">10.70389/pjs.100081</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diseases</surname><given-names>GBD</given-names></name><name name-style="western"><surname>Injuries</surname><given-names>C</given-names></name></person-group>. <article-title>Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet</source><year>2024</year>;<volume>403</volume>:<fpage>2133</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="pmid">38642570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(24)00757-8</pub-id><pub-id pub-id-type="pmcid">PMC11122111</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>The epidemiology of pregnancy loss: global burden, variable risk factors, and predictions</article-title>. <source>Hum Reprod</source><year>2024</year>;<volume>39</volume>:<fpage>834</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="pmid">38308812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/deae008</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mo</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Qin</surname><given-names>ZZ</given-names></name><name name-style="western"><surname>Ye</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>The long-term spatio-temporal trends in burden and attributable risk factors of major depressive disorder at global, regional and national levels during 1990-2019: a systematic analysis for GBD 2019</article-title>. <source>Epidemiol Psychiatr Sci</source><year>2024</year>;<volume>33</volume>:<fpage>e28</fpage>.<pub-id pub-id-type="pmid">38764153</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S2045796024000295</pub-id><pub-id pub-id-type="pmcid">PMC11362682</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fay</surname><given-names>MP</given-names></name><name name-style="western"><surname>Feuer</surname><given-names>EJ</given-names></name></person-group>. <article-title>Confidence intervals for directly standardized rates: a method based on the gamma distribution</article-title>. <source>Stat Med</source><year>1997</year>;<volume>16</volume>:<fpage>791</fpage>&#8211;<lpage>801</lpage>.<pub-id pub-id-type="pmid">9131766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1097-0258(19970415)16:7&lt;791::aid-sim500&gt;3.0.co;2-#</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019</article-title>. <source>Front Public Health</source><year>2022</year>;<volume>10</volume>:<fpage>994619</fpage>.<pub-id pub-id-type="pmid">36159285</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2022.994619</pub-id><pub-id pub-id-type="pmcid">PMC9490087</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Global trends and regional differences in the burden of anxiety disorders and major depressive disorder attributed to bullying victimisation in 204 countries and territories, 1999-2019: an analysis of the Global Burden of Disease Study</article-title>. <source>Epidemiol Psychiatr Sci</source><year>2022</year>;<volume>31</volume>:<fpage>e85</fpage>.<pub-id pub-id-type="pmid">36440549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S2045796022000683</pub-id><pub-id pub-id-type="pmcid">PMC9714217</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jha</surname><given-names>RP</given-names></name><name name-style="western"><surname>Shri</surname><given-names>N</given-names></name><name name-style="western"><surname>Patel</surname><given-names>P</given-names></name><name name-style="western"><surname>Dhamnetiya</surname><given-names>D</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>K</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M</given-names></name></person-group>. <article-title>Trends in the diabetes incidence and mortality in India from 1990 to 2019: a joinpoint and age-period-cohort analysis</article-title>. <source>J Diabetes Metab Disord</source><year>2021</year>;<volume>20</volume>:<fpage>1725</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">34900822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40200-021-00834-y</pub-id><pub-id pub-id-type="pmcid">PMC8630265</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name></person-group>. <article-title>Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021</article-title>. <source>J Headache Pain</source><year>2024</year>;<volume>25</volume>:<fpage>96</fpage>.<pub-id pub-id-type="pmid">38844846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s10194-024-01798-z</pub-id><pub-id pub-id-type="pmcid">PMC11157953</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C</given-names></name><name name-style="western"><surname>An</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mo</surname><given-names>X</given-names></name></person-group>. <article-title>The global, regional, and national patterns of change in the burden of non-malignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade</article-title>. <source>Int J Surg</source><year>2024</year>. doi:<pub-id pub-id-type="doi">10.1097/JS9.0000000000001902</pub-id>.<pub-id pub-id-type="pmcid">PMC11745775</pub-id><pub-id pub-id-type="pmid">38959095</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paik</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kabbara</surname><given-names>K</given-names></name><name name-style="western"><surname>Eberly</surname><given-names>KE</given-names></name><name name-style="western"><surname>Younossi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Henry</surname><given-names>L</given-names></name><name name-style="western"><surname>Younossi</surname><given-names>ZM</given-names></name></person-group>. <article-title>Global burden of NAFLD and chronic liver disease among adolescents and young adults</article-title>. <source>Hepatology</source><year>2022</year>;<volume>75</volume>:<fpage>1204</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="pmid">34741554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.32228</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>F</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>XX</given-names></name><etal/></person-group>. <article-title>Trends and cross-country inequalities in the global burden of osteoarthritis, 1990-2019: a population-based study</article-title>. <source>Ageing Res Rev</source><year>2024</year>;<volume>99</volume>:<fpage>102382</fpage>.<pub-id pub-id-type="pmid">38917934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arr.2024.102382</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>An</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The global, regional, and national patterns of change in the burden of congenital birth defects, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2040</article-title>. <source>EClinicalMedicine</source><year>2024</year>;<volume>77</volume>:<fpage>102873</fpage>.<pub-id pub-id-type="pmid">39416384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2024.102873</pub-id><pub-id pub-id-type="pmcid">PMC11474384</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shan</surname><given-names>S</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021</article-title>. <source>EClinicalMedicine</source><year>2024</year>;<volume>76</volume>:<fpage>102829</fpage>.<pub-id pub-id-type="pmid">39309727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2024.102829</pub-id><pub-id pub-id-type="pmcid">PMC11415963</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Miao</surname><given-names>H</given-names></name></person-group>. <article-title>Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: an analysis and comparison</article-title>. <source>Tob Induc Dis</source><year>2024</year>;<volume>22</volume>:<fpage>1</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.18332/tid/191389</pub-id><pub-id pub-id-type="pmcid">PMC11292605</pub-id><pub-id pub-id-type="pmid">39091891</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Ye</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>B</given-names></name><name name-style="western"><surname>Hou</surname><given-names>K</given-names></name></person-group>. <article-title>Epidemiological analysis of global and regional lung cancer mortality: based on 30-year data analysis of global burden disease database</article-title>. <source>Healthcare (Basel)</source><year>2023</year>;<volume>11</volume>:<fpage>2920</fpage>.<pub-id pub-id-type="pmid">37998412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/healthcare11222920</pub-id><pub-id pub-id-type="pmcid">PMC10671048</pub-id></mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Woo</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study</article-title>. <source>Lancet Healthy Longev</source><year>2025</year>;<volume>6</volume>:<fpage>100672</fpage>.<pub-id pub-id-type="pmid">39848266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lanhl.2024.100672</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050</article-title>. <source>Lancet Reg Health West Pac</source><year>2024</year>;<volume>44</volume>:<fpage>101003</fpage>.<pub-id pub-id-type="pmid">38269331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lanwpc.2023.101003</pub-id><pub-id pub-id-type="pmcid">PMC10806286</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="book"><collab>Australian Government Department of Health</collab>. <source>National Action Plan for Endometriosis</source>. EndoActive; <fpage>2018</fpage>.</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>JA</given-names></name></person-group>. <article-title>Australia&#8217;s first National Action Plan on endometriosis: progress but still a long way to go</article-title>. <source>Aust N Z J Obstet Gynaecol</source><year>2024</year>;<volume>64</volume>:<fpage>10</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="pmid">37466137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajo.13726</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olive</surname><given-names>DL</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>LB</given-names></name></person-group>. <article-title>Endometriosis</article-title>. <source>N Engl J Med</source><year>1993</year>;<volume>328</volume>:<fpage>1759</fpage>&#8211;<lpage>69</lpage>.<pub-id pub-id-type="pmid">8110213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199306173282407</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brosens</surname><given-names>I</given-names></name><name name-style="western"><surname>Gordts</surname><given-names>S</given-names></name><name name-style="western"><surname>Benagiano</surname><given-names>G</given-names></name></person-group>. <article-title>Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion</article-title>. <source>Hum Reprod</source><year>2013</year>;<volume>28</volume>:<fpage>2026</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="pmid">23739215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/det243</pub-id><pub-id pub-id-type="pmcid">PMC3712662</pub-id></mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upson</surname><given-names>K</given-names></name><name name-style="western"><surname>Sathyanarayana</surname><given-names>S</given-names></name><name name-style="western"><surname>Scholes</surname><given-names>D</given-names></name><name name-style="western"><surname>Holt</surname><given-names>VL</given-names></name></person-group>. <article-title>Early-life factors and endometriosis risk</article-title>. <source>Fertil Steril</source><year>2015</year>;<volume>104</volume>:<fpage>964</fpage>&#8211;<lpage>971e965</lpage>.<pub-id pub-id-type="pmid">26211883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2015.06.040</pub-id><pub-id pub-id-type="pmcid">PMC5328429</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vannuccini</surname><given-names>S</given-names></name><name name-style="western"><surname>Lazzeri</surname><given-names>L</given-names></name><name name-style="western"><surname>Orlandini</surname><given-names>C</given-names></name><name name-style="western"><surname>Tosti</surname><given-names>C</given-names></name><name name-style="western"><surname>Clifton</surname><given-names>VL</given-names></name><name name-style="western"><surname>Petraglia</surname><given-names>F</given-names></name></person-group>. <article-title>Potential influence of in utero and early neonatal exposures on the later development of endometriosis</article-title>. <source>Fertil Steril</source><year>2016</year>;<volume>105</volume>:<fpage>997</fpage>&#8211;<lpage>1002</lpage>.<pub-id pub-id-type="pmid">26772788</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2015.12.127</pub-id></mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farland</surname><given-names>LV</given-names></name><name name-style="western"><surname>Missmer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Bijon</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Associations among body size across the life course, adult height and endometriosis</article-title>. <source>Hum Reprod</source><year>2017</year>;<volume>32</volume>:<fpage>1732</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">28591798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/dex207</pub-id><pub-id pub-id-type="pmcid">PMC5850750</pub-id></mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>DK</given-names></name><name name-style="western"><surname>Correia</surname><given-names>KF</given-names></name><name name-style="western"><surname>Vitonis</surname><given-names>AF</given-names></name><name name-style="western"><surname>Missmer</surname><given-names>SA</given-names></name></person-group>. <article-title>Body size and endometriosis: results from 20 years of follow-up within the Nurses&#8217; Health Study II prospective cohort</article-title>. <source>Hum Reprod</source><year>2013</year>;<volume>28</volume>:<fpage>1783</fpage>&#8211;<lpage>92</lpage>.<pub-id pub-id-type="pmid">23674552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/det120</pub-id><pub-id pub-id-type="pmcid">PMC3685336</pub-id></mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>S</given-names></name><name name-style="western"><surname>Banu</surname><given-names>SK</given-names></name><name name-style="western"><surname>Arosh</surname><given-names>JA</given-names></name></person-group>. <article-title>Endocrine disruptors and endometriosis</article-title>. <source>Reprod Toxicol</source><year>2023</year>;<volume>115</volume>:<fpage>56</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">36436816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.reprotox.2022.11.007</pub-id></mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herup-Wheeler</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>M</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>High-fat diets promote peritoneal inflammation and augment endometriosis-associated abdominal hyperalgesia</article-title>. <source>Front Endocrinol (Lausanne)</source><year>2024</year>;<volume>15</volume>:<fpage>1336496</fpage>.<pub-id pub-id-type="pmid">38559689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2024.1336496</pub-id><pub-id pub-id-type="pmcid">PMC10978581</pub-id></mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguirre</surname><given-names>KIA</given-names></name></person-group>. <article-title>Pesticides and endometriosis: silent links in our everyday environment</article-title>. <source>Explore (NY)</source><year>2024</year>;<volume>20</volume>:<fpage>148</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="pmid">38155058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.explore.2023.12.006</pub-id></mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmioglu</surname><given-names>N</given-names></name><name name-style="western"><surname>Mortlock</surname><given-names>S</given-names></name><name name-style="western"><surname>Ghiasi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions</article-title>. <source>Nat Genet</source><year>2023</year>;<volume>55</volume>:<fpage>423</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">36914876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-023-01323-z</pub-id><pub-id pub-id-type="pmcid">PMC10042257</pub-id></mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Imanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoshimoto</surname><given-names>C</given-names></name><name name-style="western"><surname>Matsubara</surname><given-names>S</given-names></name><name name-style="western"><surname>Shigetomi</surname><given-names>H</given-names></name></person-group>. <article-title>Rethinking the pathogenesis of endometriosis: complex interactions of genomic, epigenetic, and environmental factors</article-title>. <source>J Obstet Gynaecol Res</source><year>2024</year>;<volume>50</volume>:<fpage>1771</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="pmid">39293995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jog.16089</pub-id></mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stirbu</surname><given-names>I</given-names></name><name name-style="western"><surname>Kunst</surname><given-names>AE</given-names></name><name name-style="western"><surname>Mielck</surname><given-names>A</given-names></name><name name-style="western"><surname>Mackenbach</surname><given-names>JP</given-names></name></person-group>. <article-title>Inequalities in utilisation of general practitioner and specialist services in 9 European countries</article-title>. <source>BMC Health Serv Res</source><year>2011</year>;<volume>11</volume>:<fpage>288</fpage>.<pub-id pub-id-type="pmid">22040155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6963-11-288</pub-id><pub-id pub-id-type="pmcid">PMC3221557</pub-id></mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filc</surname><given-names>D</given-names></name><name name-style="western"><surname>Davidovich</surname><given-names>N</given-names></name><name name-style="western"><surname>Novack</surname><given-names>L</given-names></name><name name-style="western"><surname>Balicer</surname><given-names>RD</given-names></name></person-group>. <article-title>Is socioeconomic status associated with utilization of health care services in a single-payer universal health care system?</article-title><source>Int J Equity Health</source><year>2014</year>;<volume>13</volume>:<fpage>115</fpage>.<pub-id pub-id-type="pmid">25431139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12939-014-0115-1</pub-id><pub-id pub-id-type="pmcid">PMC4260253</pub-id></mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bougie</surname><given-names>O</given-names></name><name name-style="western"><surname>Yap</surname><given-names>MI</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>L</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>T</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name></person-group>. <article-title>Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis</article-title>. <source>BJOG</source><year>2019</year>;<volume>126</volume>:<fpage>1104</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">30908874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1471-0528.15692</pub-id></mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parazzini</surname><given-names>F</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>G</given-names></name><name name-style="western"><surname>Tozzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Noli</surname><given-names>S</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>S</given-names></name></person-group>. <article-title>Epidemiology of endometriosis and its comorbidities</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source><year>2017</year>;<volume>209</volume>:<fpage>3</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">27216973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejogrb.2016.04.021</pub-id></mixed-citation></ref><ref id="R57"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapron</surname><given-names>C</given-names></name><name name-style="western"><surname>Lang</surname><given-names>JH</given-names></name><name name-style="western"><surname>Leng</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>Factors and regional differences associated with endometriosis: a multi-country, case-control study</article-title>. <source>Adv Ther</source><year>2016</year>;<volume>33</volume>:<fpage>1385</fpage>&#8211;<lpage>407</lpage>.<pub-id pub-id-type="pmid">27342743</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12325-016-0366-x</pub-id><pub-id pub-id-type="pmcid">PMC4969328</pub-id></mixed-citation></ref><ref id="R58"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiser</surname><given-names>AC</given-names></name><name name-style="western"><surname>Hemmert</surname><given-names>R</given-names></name><name name-style="western"><surname>Myrer</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Validation of administrative health data for the identification of endometriosis diagnosis</article-title>. <source>Hum Reprod</source><year>2025</year>;<volume>40</volume>:<fpage>289</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="pmid">39704741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humrep/deae281</pub-id><pub-id pub-id-type="pmcid">PMC11788219</pub-id></mixed-citation></ref><ref id="R59"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasamoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L</given-names></name><name name-style="western"><surname>Vitonis</surname><given-names>AF</given-names></name><etal/></person-group>. <article-title>Plasma proteins and persistent postsurgical pelvic pain among adolescents and young adults with endometriosis</article-title>. <source>Am J Obstet Gynecol</source><year>2024</year>;<volume>231</volume>:<fpage>240e241</fpage>&#8211;<lpage>240e211</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2024.03.005</pub-id><pub-id pub-id-type="pmcid">PMC11975416</pub-id><pub-id pub-id-type="pmid">38462144</pub-id></mixed-citation></ref><ref id="R60"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>MW</given-names></name><name name-style="western"><surname>Rosin</surname><given-names>A</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Longer operative times but equally safe - a propensity score-matched analysis for laparoscopic procedures in women with early-stage (r-ASRM I-II) endometriosis performed by gynecology residents compared to attending surgeons</article-title>. <source>BMC Med Educ</source><year>2025</year>;<volume>25</volume>:<fpage>450</fpage>.<pub-id pub-id-type="pmid">40148842</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12909-025-06952-y</pub-id><pub-id pub-id-type="pmcid">PMC11951770</pub-id></mixed-citation></ref><ref id="R61"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Movilla</surname><given-names>P</given-names></name><name name-style="western"><surname>van Reesema</surname><given-names>L</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Impact of race and ethnicity on perioperative outcomes during hysterectomy for endometriosis</article-title>. <source>J Minim Invasive Gynecol</source><year>2022</year>;<volume>29</volume>:<fpage>1268</fpage>&#8211;<lpage>77</lpage>.<pub-id pub-id-type="pmid">36130704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmig.2022.09.005</pub-id></mixed-citation></ref><ref id="R62"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bandala</surname><given-names>C</given-names></name><name name-style="western"><surname>Cifuentes-Chacon</surname><given-names>JP</given-names></name><name name-style="western"><surname>Cortes-Vazquez</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruz-Barros</surname><given-names>R</given-names></name><name name-style="western"><surname>Garrocho-Hernandez</surname><given-names>L</given-names></name><name name-style="western"><surname>Cortes-Algara</surname><given-names>A</given-names></name></person-group>. <article-title>Efficacy between conventional laparoscopy and robotic surgery in mexican patients with endometriosis: a comparative study</article-title>. <source>J Clin Med</source><year>2024</year>;<volume>13</volume>:<fpage>3576</fpage>.<pub-id pub-id-type="pmid">38930105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm13123576</pub-id><pub-id pub-id-type="pmcid">PMC11205068</pub-id></mixed-citation></ref><ref id="R63"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebrahimi</surname><given-names>M</given-names></name><name name-style="western"><surname>Naghdi</surname><given-names>S</given-names></name><name name-style="western"><surname>Davari-Tanha</surname><given-names>F</given-names></name><name name-style="western"><surname>Moradi</surname><given-names>B</given-names></name><name name-style="western"><surname>Feizabad</surname><given-names>E</given-names></name><name name-style="western"><surname>Majidi</surname><given-names>K</given-names></name></person-group>. <article-title>Value of ultrasound-based endometriosis staging system in anticipating complexity of laparoscopic surgery</article-title>. <source>Fertil Steril</source><year>2025</year>;<volume>123</volume>:<fpage>893</fpage>&#8211;<lpage>98</lpage>.<pub-id pub-id-type="pmid">39577829</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2024.11.018</pub-id></mixed-citation></ref><ref id="R64"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavone</surname><given-names>M</given-names></name><name name-style="western"><surname>Baroni</surname><given-names>A</given-names></name><name name-style="western"><surname>Campolo</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Robotic assisted versus laparoscopic surgery for deep endometriosis: a meta-analysis of current evidence</article-title>. <source>J Rob Surg</source><year>2024</year>;<volume>18</volume>:<fpage>212</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11701-024-01954-2</pub-id><pub-id pub-id-type="pmcid">PMC11098866</pub-id><pub-id pub-id-type="pmid">38753180</pub-id></mixed-citation></ref><ref id="R65"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name></person-group>. <article-title>Systematic review and meta-analysis: impact of various hemostasis methods on ovarian reserve function in laparoscopic cystectomy for ovarian endometriomas</article-title>. <source>Altern Ther Health Med</source><year>2024</year>;<volume>30</volume>:<fpage>312</fpage>&#8211;<lpage>19</lpage>.<pub-id pub-id-type="pmid">38064608</pub-id></mixed-citation></ref><ref id="R66"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>P</given-names></name><name name-style="western"><surname>Lukey</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status</article-title>. <source>Am J Obstet Gynecol</source><year>2023</year>;<volume>228</volume>:<fpage>57e51</fpage>&#8211;<lpage>57e18</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2022.08.044</pub-id><pub-id pub-id-type="pmid">36029832</pub-id></mixed-citation></ref><ref id="R67"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janssen</surname><given-names>EB</given-names></name><name name-style="western"><surname>Rijkers</surname><given-names>AC</given-names></name><name name-style="western"><surname>Hoppenbrouwers</surname><given-names>K</given-names></name><name name-style="western"><surname>Meuleman</surname><given-names>C</given-names></name><name name-style="western"><surname>D&#8217;Hooghe</surname><given-names>TM</given-names></name></person-group>. <article-title>Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review</article-title>. <source>Hum Reprod Update</source><year>2013</year>;<volume>19</volume>:<fpage>570</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">23727940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humupd/dmt016</pub-id></mixed-citation></ref><ref id="R68"><label>[68]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zondervan</surname><given-names>KT</given-names></name><name name-style="western"><surname>Yudkin</surname><given-names>PL</given-names></name><name name-style="western"><surname>Vessey</surname><given-names>MP</given-names></name><etal/></person-group>. <article-title>Chronic pelvic pain in the community&#8211;symptoms, investigations, and diagnoses</article-title>. <source>Am J Obstet Gynecol</source><year>2001</year>;<volume>184</volume>:<fpage>1149</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="pmid">11349181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mob.2001.112904</pub-id></mixed-citation></ref><ref id="R69"><label>[69]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballard</surname><given-names>K</given-names></name><name name-style="western"><surname>Lowton</surname><given-names>K</given-names></name><name name-style="western"><surname>Wright</surname><given-names>J</given-names></name></person-group>. <article-title>What&#8217;s the delay? A qualitative study of women&#8217;s experiences of reaching a diagnosis of endometriosis</article-title>. <source>Fertil Steril</source><year>2006</year>;<volume>86</volume>:<fpage>1296</fpage>&#8211;<lpage>301</lpage>.<pub-id pub-id-type="pmid">17070183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2006.04.054</pub-id></mixed-citation></ref><ref id="R70"><label>[70]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapron</surname><given-names>C</given-names></name><name name-style="western"><surname>Vannuccini</surname><given-names>S</given-names></name><name name-style="western"><surname>Santulli</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Diagnosing adenomyosis: an integrated clinical and imaging approach</article-title>. <source>Hum Reprod Update</source><year>2020</year>;<volume>26</volume>:<fpage>392</fpage>&#8211;<lpage>411</lpage>.<pub-id pub-id-type="pmid">32097456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/humupd/dmz049</pub-id></mixed-citation></ref><ref id="R71"><label>[71]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nisenblat</surname><given-names>V</given-names></name><name name-style="western"><surname>Bossuyt</surname><given-names>PM</given-names></name><name name-style="western"><surname>Farquhar</surname><given-names>C</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>N</given-names></name><name name-style="western"><surname>Hull</surname><given-names>ML</given-names></name></person-group>. <article-title>Imaging modalities for the non-invasive diagnosis of endometriosis</article-title>. <source>Cochrane Database Syst Rev</source><year>2016</year>;<volume>2</volume>:<fpage>CD009591</fpage>.<pub-id pub-id-type="pmid">26919512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD009591.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7100540</pub-id></mixed-citation></ref><ref id="R72"><label>[72]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Allaire</surname><given-names>C</given-names></name><name name-style="western"><surname>Al-Nourhji</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Guideline no. 449: diagnosis and impact of endometriosis &#8211; a Canadian guideline</article-title>. <source>J Obstet Gynaecol Can</source><year>2024</year>;<volume>46</volume>:<fpage>102450</fpage>.<pub-id pub-id-type="pmid">38555044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jogc.2024.102450</pub-id></mixed-citation></ref><ref id="R73"><label>[73]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swift</surname><given-names>B</given-names></name><name name-style="western"><surname>Taneri</surname><given-names>B</given-names></name><name name-style="western"><surname>Becker</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean population</article-title>. <source>Eur J Public Health</source><year>2024</year>;<volume>34</volume>:<fpage>244</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">38070492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurpub/ckad216</pub-id><pub-id pub-id-type="pmcid">PMC10990517</pub-id></mixed-citation></ref><ref id="R74"><label>[74]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rowlands</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Abbott</surname><given-names>JA</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>GW</given-names></name><name name-style="western"><surname>Hockey</surname><given-names>R</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>P</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>GD</given-names></name></person-group>. <article-title>Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study</article-title>. <source>BJOG</source><year>2021</year>;<volume>128</volume>:<fpage>657</fpage>&#8211;<lpage>65</lpage>.<pub-id pub-id-type="pmid">32757329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1471-0528.16447</pub-id></mixed-citation></ref><ref id="R75"><label>[75]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medina-Perucha</surname><given-names>L</given-names></name><name name-style="western"><surname>Pistillo</surname><given-names>A</given-names></name><name name-style="western"><surname>Raventos</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Endometriosis prevalence and incidence trends in a large population-based study in Catalonia (Spain) from 2009 to 2018</article-title>. <source>Womens Health (Lond)</source><year>2022</year>;<volume>18</volume>:<fpage>17455057221130566</fpage>.<pub-id pub-id-type="pmid">36281527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/17455057221130566</pub-id><pub-id pub-id-type="pmcid">PMC9608029</pub-id></mixed-citation></ref><ref id="R76"><label>[76]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christ</surname><given-names>JP</given-names></name><name name-style="western"><surname>Yu</surname><given-names>O</given-names></name><name name-style="western"><surname>Schulze-Rath</surname><given-names>R</given-names></name><name name-style="western"><surname>Grafton</surname><given-names>J</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>K</given-names></name><name name-style="western"><surname>Reed</surname><given-names>SD</given-names></name></person-group>. <article-title>Incidence, prevalence, and trends in endometriosis diagnosis: a United States population-based study from 2006 to 2015</article-title>. <source>Am J Obstet Gynecol</source><year>2021</year>;<volume>225</volume>:<fpage>500e501</fpage>&#8211;<lpage>500e509</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2021.06.067</pub-id><pub-id pub-id-type="pmid">34147493</pub-id></mixed-citation></ref><ref id="R77"><label>[77]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nnoaham</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hummelshoj</surname><given-names>L</given-names></name><name name-style="western"><surname>Webster</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>World endometriosis research foundation global study of women&#8217;s health, c. impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries</article-title>. <source>Fertil Steril</source><year>2011</year>;<volume>96</volume>:<fpage>366</fpage>&#8211;<lpage>373e368</lpage>.<pub-id pub-id-type="pmid">21718982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2011.05.090</pub-id><pub-id pub-id-type="pmcid">PMC3679489</pub-id></mixed-citation></ref><ref id="R78"><label>[78]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballweg</surname><given-names>ML</given-names></name></person-group>. <article-title>Treating endometriosis in adolescents: does it matter?</article-title><source>J Pediatr Adolesc Gynecol</source><year>2011</year>;<volume>24</volume>:<fpage>S2</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21856547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpag.2011.07.003</pub-id></mixed-citation></ref><ref id="R79"><label>[79]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventolini</surname><given-names>G</given-names></name><name name-style="western"><surname>Horowitz</surname><given-names>GM</given-names></name><name name-style="western"><surname>Long</surname><given-names>R</given-names></name></person-group>. <article-title>Endometriosis in adolescence: a long-term follow-up fecundability assessment</article-title>. <source>Reprod Biol Endocrinol</source><year>2005</year>;<volume>3</volume>:<fpage>14</fpage>.<pub-id pub-id-type="pmid">15845149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1477-7827-3-14</pub-id><pub-id pub-id-type="pmcid">PMC1131922</pub-id></mixed-citation></ref><ref id="R80"><label>[80]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giamberardino</surname><given-names>MA</given-names></name><name name-style="western"><surname>Tana</surname><given-names>C</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>R</given-names></name></person-group>. <article-title>Pain thresholds in women with chronic pelvic pain</article-title>. <source>Curr Opin Obstet Gynecol</source><year>2014</year>;<volume>26</volume>:<fpage>253</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="pmid">24921647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/GCO.0000000000000083</pub-id></mixed-citation></ref><ref id="R81"><label>[81]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laufer</surname><given-names>MR</given-names></name><name name-style="western"><surname>Sanfilippo</surname><given-names>J</given-names></name><name name-style="western"><surname>Rose</surname><given-names>G</given-names></name></person-group>. <article-title>Adolescent endometriosis: diagnosis and treatment approaches</article-title>. <source>J Pediatr Adolesc Gynecol</source><year>2003</year>;<volume>16</volume>:<fpage>S3</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="pmid">12742180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1083-3188(03)00066-4</pub-id></mixed-citation></ref><ref id="R82"><label>[82]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitonis</surname><given-names>AF</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>K</given-names></name><name name-style="western"><surname>Rahmioglu</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>World endometriosis research foundation endometriosis phenome and biobanking harmonization project: II</article-title>. <source>Clinical and Covariate Phenotype Data Collection in Endometriosis Research. Fertil Steril</source><year>2014</year>;<volume>102</volume>:<fpage>1223</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2014.07.1244</pub-id><pub-id pub-id-type="pmcid">PMC4252538</pub-id><pub-id pub-id-type="pmid">25256930</pub-id></mixed-citation></ref><ref id="R83"><label>[83]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>L</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021</article-title>. <source>EClinicalMedicine</source><year>2025</year>;<volume>80</volume>:<fpage>103051</fpage>.<pub-id pub-id-type="pmid">39867965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2024.103051</pub-id><pub-id pub-id-type="pmcid">PMC11764843</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>